MCID: PRT037
MIFTS: 65

Pertussis

Categories: Infectious diseases, Rare diseases, Respiratory diseases, Smell/Taste diseases

Aliases & Classifications for Pertussis

MalaCards integrated aliases for Pertussis:

Name: Pertussis 12 74 52 58 3 15 71
Whooping Cough 12 74 52 58 42 3 15 17 32
Bordetella Infections 43 17 71
Whooping Cough Due to Unspecified Organism 71
Bordetella Pertussis Infection 52
Bordetella Infection 12
Wc - Whooping Cough 12

Characteristics:

Orphanet epidemiological data:

58
whooping cough
Prevalence: 1-9/100000 (Europe); Age of onset: All ages; Age of death: any age;

Classifications:

Orphanet: 58  
Rare infectious diseases


External Ids:

Disease Ontology 12 DOID:1116
MeSH 43 D001885
MESH via Orphanet 44 D014917
ICD10 via Orphanet 33 A37.0 A37.1 A37.8 more
UMLS via Orphanet 72 C0043167 C0043168
Orphanet 58 ORPHA1489
UMLS 71 C0006015 C0043167 C0043168

Summaries for Pertussis

MedlinePlus : 42 Whooping cough is an infectious bacterial disease that causes uncontrollable coughing. The name comes from the noise you make when you take a breath after you cough. You may have choking spells or may cough so hard that you vomit. Anyone can get whooping cough, but it is more common in infants and children. It's especially dangerous for infants. The coughing spells can be so bad that it is hard for infants to eat, drink, or breathe. To make a diagnosis, your doctor may do a physical exam, blood tests, chest x-rays, or nose or throat cultures. Before there was a vaccine, whooping cough was one of the most common childhood diseases and a major cause of childhood deaths in the U.S. Now most cases are prevented by vaccines. If you have whooping cough, treatment with antibiotics may help if given early. Centers for Disease Control and Prevention

MalaCards based summary : Pertussis, also known as whooping cough, is related to tetanus and haemophilus influenzae, and has symptoms including fever, pruritus and snoring. An important gene associated with Pertussis is TLR4 (Toll Like Receptor 4), and among its related pathways/superpathways are Pertussis and Innate Immune System. The drugs Montelukast and Edetic Acid have been mentioned in the context of this disorder. Affiliated tissues include respiratory tract, neutrophil and smooth muscle, and related phenotypes are Synthetic lethal with MLN4924 (a NAE inhibitor) and Synthetic lethal with MLN4924 (a NAE inhibitor)

Disease Ontology : 12 A commensal bacterial infectious disease that results in inflammation located in respiratory tract, has material basis in Bordetella pertussis, or has material basis in Bordetella parapertussis, which produce toxins that paralyze the cilia of the respiratory epithelial cells. The infection is characterized by a prolonged, high-pitched, deeply indrawn breath (whoop).

CDC : 3 Pertussis, also known as whooping cough, is a highly contagious respiratory disease. It is caused by the bacterium Bordetella pertussis. Pertussis is known for uncontrollable, violent coughing which often makes it hard to breathe. After cough fits, someone with pertussis often needs to take deep breaths, which result in a "whooping" sound. Pertussis can affect people of all ages, but can be very serious, even deadly, for babies less than a year old. The best way to protect against pertussis is by getting vaccinated

Wikipedia : 74 Whooping cough, also known as pertussis or the 100-day cough, is a highly contagious bacterial disease.... more...

Related Diseases for Pertussis

Diseases related to Pertussis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 834)
# Related Disease Score Top Affiliating Genes
1 tetanus 32.2 TNF IL6 IL1B IL1A IL10
2 haemophilus influenzae 31.9 TNF CXCL8
3 cholera 31.5 TNF IL6 IL1B GNAI1 FOS CXCL8
4 rubella 31.3 TNF TLR4 IL6 IL1B IL10
5 measles 31.3 TNF TLR4 MYD88 IL6 IL1B CXCL8
6 mumps 31.3 TNF IL6 IL1B IL10 CXCL8
7 pulmonary hypertension 31.1 TNF IL6 IL1B IL10 CXCL8
8 encephalitis 31.1 TNF IL6 IL1B IL10
9 pain agnosia 31.1 OPRM1 IL6 IL1B FOS
10 chickenpox 31.0 TNF IL6 IL10
11 neutrophil migration 31.0 MAPK1 ITGB2 ITGAM CXCL8
12 pleurisy 30.9 TNF TLR4 CXCL8
13 hepatitis a 30.9 TNF TLR4 IL1B IL10 CXCL8
14 respiratory failure 30.8 TNF TLR4 JUN IL6 IL1B IL10
15 lymphocytic choriomeningitis 30.8 MYD88 IL6 CXCL8
16 amebiasis 30.8 TNF TLR4 IL1B CXCL8
17 food allergy 30.8 TNF TLR4 IL10 CXCL8
18 bronchiolitis 30.8 TNF TLR4 IL6 IL1A IL10 CXCL8
19 allergic asthma 30.8 TLR4 ITGB2 ITGAM IL10 CXCL8
20 typhoid fever 30.8 TNF TLR4 IL6 IL1B IL1A
21 bronchopneumonia 30.7 TNF TLR4 IL6 IL1B IL10 CXCL8
22 bronchitis 30.7 TNF TLR4 IL6 IL1B IL10 CXCL8
23 sleep disorder 30.7 TNF IL6 IL1B FOS
24 sudden infant death syndrome 30.7 TNF IL6 IL1B IL1A IL10 CXCL8
25 neuroblastoma 30.7 TNF OPRM1 MAPK1 JUN IL6 IL1B
26 erythema multiforme 30.6 TNF IL6 CXCL8
27 bone resorption disease 30.6 TNF IL6 IL1B FOS
28 autoimmune uveitis 30.6 TNF IL1B IL10
29 exanthem 30.6 TNF IL6 IL1B IL10 CXCL8
30 influenza 30.6 TNF TLR4 MYD88 IL6 IL1B IL1A
31 post-transplant lymphoproliferative disease 30.6 TNF IL6 IL1A IL10
32 meningoencephalitis 30.6 TNF IL6 IL1B IL10
33 morphine dependence 30.6 OPRM1 FOS ADCY10
34 hepatitis b 30.6 TNF TLR4 MYD88 IL6 FOS CXCL8
35 thyroiditis 30.6 TNF IL6 IL10
36 neuritis 30.5 TNF IL6 IL1B IL10 CXCL8
37 laryngitis 30.5 TNF IL6 IL1B IL1A
38 myelitis 30.5 TNF IL6 IL10 CXCL8
39 orchitis 30.5 TNF IL6 IL1B IL10
40 pulmonary edema 30.5 TNF IL1B IL10 CXCL8
41 cellulitis 30.5 TNF IL6 IL1B IL10
42 autoimmune disease 30.4 TNF ITGAM IL6 IL1B IL1A IL10
43 chlamydia pneumonia 30.4 TNF TLR4 IL6 IL1B IL10 CXCL8
44 leprosy 3 30.4 TNF TLR4 IL6 IL1B IL10 CXCL8
45 leukostasis 30.4 TNF IL6 IL1B
46 purpura 30.4 TNF IL6 IL10
47 fibrosarcoma 30.4 TNF MAPK1 JUN IL1A FOS
48 stomatitis 30.4 TNF TLR4 IL6 IL1B IL10 CXCL8
49 tularemia 30.4 TNF TLR4 MYD88 IL1B
50 bacterial pneumonia 30.4 TNF TLR4 IL6 IL1B IL10 CXCL8

Graphical network of the top 20 diseases related to Pertussis:



Diseases related to Pertussis

Symptoms & Phenotypes for Pertussis

UMLS symptoms related to Pertussis:


fever, pruritus, snoring, coughing

GenomeRNAi Phenotypes related to Pertussis according to GeneCards Suite gene sharing:

26
# Description GenomeRNAi Source Accession Score Top Affiliating Genes
1 Synthetic lethal with MLN4924 (a NAE inhibitor) GR00250-A-1 9.47 CXCL8 IL10 IL1A IL1B JUN MYD88
2 Synthetic lethal with MLN4924 (a NAE inhibitor) GR00250-A-2 9.47 CXCL8 IL10 IL1B JUN MYD88 TNF
3 Synthetic lethal with MLN4924 (a NAE inhibitor) GR00250-A-3 9.47 JUN

MGI Mouse Phenotypes related to Pertussis:

45 (show all 13)
# Description MGI Source Accession Score Top Affiliating Genes
1 homeostasis/metabolism MP:0005376 10.39 ADCY10 FOS GNAI1 GNAZ IL10 IL1A
2 hematopoietic system MP:0005397 10.38 FOS GNAI1 GNAZ IL10 IL1A IL1B
3 cellular MP:0005384 10.31 ADCY10 FOS IL10 IL6 ITGAM ITGB2
4 behavior/neurological MP:0005386 10.3 FOS GNAI1 GNAZ IL10 IL6 JUN
5 cardiovascular system MP:0005385 10.29 ADCY10 IL10 IL1A IL1B IL6 ITGB2
6 immune system MP:0005387 10.28 FOS GNAI1 IL10 IL1A IL1B IL6
7 nervous system MP:0003631 10.2 FOS GNAI1 GNAZ IL10 IL1B IL6
8 integument MP:0010771 10.18 FOS GNAZ IL10 IL1A IL1B IL6
9 neoplasm MP:0002006 10.02 FOS IL10 IL1A IL1B IL6 MAPK1
10 no phenotypic analysis MP:0003012 9.86 ADCY10 GNAI1 IL10 JUN MAPK10 MYD88
11 reproductive system MP:0005389 9.85 ADCY10 FOS GNAZ IL10 IL6 MAPK1
12 skeleton MP:0005390 9.7 FOS GNAI1 IL10 IL1B IL6 ITGB2
13 vision/eye MP:0005391 9.28 FOS IL10 IL6 ITGB2 JUN MAPK1

Drugs & Therapeutics for Pertussis

Drugs for Pertussis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 141)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Montelukast Approved Phase 4 158966-92-8 5281040
2
Edetic Acid Approved, Vet_approved Phase 4 60-00-4, 62-33-9 6049
3
Iron Approved, Experimental Phase 4 15438-31-0, 7439-89-6 27284 23925
4
Pentetic acid Approved Phase 4 67-43-6
5
Ceftriaxone Approved Phase 4 73384-59-5 5361919 5479530
6
BCG vaccine Investigational Phase 4
7 Leukotriene Antagonists Phase 4
8 Vaccines Phase 4
9 Antitoxins Phase 4
10 Heptavalent Pneumococcal Conjugate Vaccine Phase 4
11 Adjuvants, Immunologic Phase 4
12 Aluminum phosphate Phase 4
13 Antidotes Phase 4
14 Chelating Agents Phase 4
15 Iron Chelating Agents Phase 4
16 Calcium, Dietary Phase 4
17 Anticoagulants Phase 4
18 Micronutrients Phase 4
19 Trace Elements Phase 4
20 Chrysanthemum Phase 4
21 Antibodies Phase 4
22 Immunoglobulins Phase 4
23
Calcium Nutraceutical Phase 4 7440-70-2 271
24
Deferiprone Approved Phase 3 30652-11-0 2972
25
Lactitol Approved, Investigational Phase 3 585-88-6, 585-86-4 493591
26
Aluminum hydroxide Approved, Investigational Phase 3 21645-51-2
27
tannic acid Approved Phase 3 1401-55-4
28
Benzocaine Approved, Investigational Phase 3 94-09-7, 1994-09-7 2337
29
Prednisone Approved, Vet_approved Phase 3 53-03-2 5865
30 Benralizumab Approved, Investigational Phase 2, Phase 3 1044511-01-4
31 Rho(D) Immune Globulin Phase 3
32 gamma-Globulins Phase 3
33 Hemagglutinins Phase 3
34 Laxatives Phase 3
35 Cathartics Phase 3
36 taxane Phase 3
37 Pharmaceutical Solutions Phase 3
38 Respiratory System Agents Phase 2, Phase 3
39 Anti-Asthmatic Agents Phase 2, Phase 3
40
Histidine Investigational, Nutraceutical Phase 2, Phase 3 71-00-1 6274
41
Aluminum sulfate Approved Phase 1, Phase 2 10043-01-3
42
Ibuprofen Approved Phase 2 15687-27-1 3672
43
Prednisolone phosphate Approved, Vet_approved Phase 1, Phase 2 302-25-0
44
Methylprednisolone Approved, Vet_approved Phase 1, Phase 2 83-43-2 6741
45
Methylprednisolone hemisuccinate Approved Phase 1, Phase 2 2921-57-5
46 Prednisolone acetate Approved, Vet_approved Phase 1, Phase 2 52-21-1
47
Prednisolone Approved, Vet_approved Phase 1, Phase 2 50-24-8 5755
48
Clotrimazole Approved, Vet_approved Phase 1, Phase 2 23593-75-1 2812
49
Miconazole Approved, Investigational, Vet_approved Phase 1, Phase 2 22916-47-8 4189
50
Basiliximab Approved, Investigational Phase 1, Phase 2 152923-56-3, 179045-86-4

Interventional clinical trials:

(show top 50) (show all 429)
# Name Status NCT ID Phase Drugs
1 Safety and Immunogenicity of Adult Formulation Tetanus and Diphtheria Toxoids Adsorbed Combined With Acellular Pertussis (Tdap) Vaccine Following Blood and Morrow Transplantation in Adults Unknown status NCT00336115 Phase 4
2 Open Label Multicentric Randomized Phase IV Post Marketing Safety, Immunogenicity and Lot-to-Lot Consistency Analysis of Shan 5 [DTPwHB-Hib (Liquid) Pentavalent Combination Vaccine] in Indian Infants Unknown status NCT00877357 Phase 4
3 The Efficacy and Safety of Vaccination Against Pertussis. Tetanus and Diphtheria in Patients Suffering From Rheumatoid Arthritis Unknown status NCT01301703 Phase 4
4 Comparison of Two Vaccinal Schemes for DTP-Pertussis-Hib Primo-immunisation in Very Preterm-born Neonates: a Randomised Bicentric Controlled Study Unknown status NCT02179996 Phase 4
5 The Influence of BCG Vaccine as a Booster TDaP-IPV Vaccination: an Explorative Study Unknown status NCT02771782 Phase 4
6 An Immunogenicity and Safety Study of Combined Adsorbed Tetanus, Low Dose Diphtheria and Acellular Pertussis Vaccine (Td5ap and Td1aP) Given as a School-leaving Booster to 14-15-year-old Children Primed With a Five Component Acellular Pertussis Vaccine at 3, 5 and 12 Months of Age, and a Booster Dose at 5½ Years of Age Unknown status NCT00870350 Phase 4
7 Clinical Study to Generate a Set of Data Characterising Clinical Events, Physiological Responses, and Innate and Adaptive Immune Responses Following a Single IM Immunisation With Boostrix® or Placebo in Healthy Adults Unknown status NCT02555540 Phase 4
8 A Double Blind Randomised Placebo Controlled Trial of Montelukast in the Treatment of Acute Persistent Cough in Young People and Adults in Primary Care Unknown status NCT01279668 Phase 4 Montelukast;Placebo
9 Safety Among Adolescents and Adults of Revaccination With Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine Adsorbed (Adacel®) 4 to 5 Years After a Previous Dose Completed NCT00347958 Phase 4
10 Comparison in US Adolescents of the Safety and Immunogenicity of Two Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis (Tdap) Vaccines: ADACEL™ and BOOSTRIX® Completed NCT00319553 Phase 4
11 A Randomised Controlled Trial Comparing Two Pertussis-containing Vaccines in Pregnancy and Vaccine Responses in UK Mothers and Their Infants Completed NCT02145624 Phase 4 Repevax;Boostrix-IPV
12 An Open Label Multicentric Study to Evaluate the Immunogenicity and Safety of Indigenously Developed DTPwHB-Hib (Liquid) Pentavalent Combination Vaccine (Shan 5) in Indian Infants. Completed NCT00617812 Phase 4
13 Immune Responses in Adults to Revaccination With Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine Adsorbed (ADACEL®) 10 Years After a Previous Dose Completed NCT00712959 Phase 4
14 Regulatory Post-Marketing Surveillance (PMS) Study for ADACEL™ (Adsorbed Diphtheria, Tetanus Toxoids and Component Pertussis Combined Vaccine for Adult) Completed NCT01137435 Phase 4
15 Evaluation of GSK Biologicals' dTpa Booster Vaccine in Young Adults 10 Years After Previous dTpa Boosting. Completed NCT00610168 Phase 4
16 A Single Blind, Multicentric, Comparative, Vaccine Interchangeability Trial of Shan 5 (Liquid) and Easy Five (Liquid) [Diphtheria-Tetanus- Pertussis, Hepatitis B and Hib Pentavalent Combination Vaccines] in Indian Infants. Completed NCT00674908 Phase 4
17 Safety and Immunogenicity of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine Adsorbed (ADACEL®) in Persons ≥65 Years of Age Completed NCT00457249 Phase 4
18 A Phase III/IV Randomised Open-label Study and Comparison of the Immunogenicity and Safety of a Single Adolescent Booster Dose of a Meningococcal Group C Conjugate-containing Booster Vaccine (Meningitec™, OR NeisVac-C™ , OR Menitorix™), When Given Concurrently With an Acellular Pertussis-containing Booster Vaccine (Repevax™ or IPV-Boostrix™) Completed NCT02526394 Phase 4 Pertussis containing vaccine
19 Reactogenicity of Acellular Pertussis Vaccine Booster in Adolescents Who Have Received 5 Prior Doses of BIKEN Acellular Pertussis Vaccine in Combination With Diphtheria and Tetanus Toxoids (TRIPEDIA®) or Who Have Received Primary Vaccination With 3 Doses of Whole-Cell Pertussis Vaccine, Plus at Least 1 Pertussis Booster Vaccination Completed NCT00304265 Phase 4
20 Vaccine Responses in Infants After Acellular Pertussis Vaccination During Pregnancy in Thailand Completed NCT02408926 Phase 4
21 Immunogenicity and Safety of Sanofi Pasteur Pentaxim Combined Vaccine in Infants in Thailand Completed NCT00255021 Phase 4
22 Evaluation of GSK Biological's dTpa-IPV Booster Vaccine in Children and Adolescents, 5 Years After Previous dTpa-IPV Boosting. Completed NCT00635128 Phase 4
23 Immunogenicity of Adacel® and BOOSTRIX® Vaccines in Adolescents Completed NCT01629589 Phase 4
24 Safety and Immunogenicity in Adults of Revaccination With Adacel® Vaccine 10 Years After a Previous Dose Completed NCT01439165 Phase 4
25 Impact of Pertussis Vaccination in Pregnancy on Maternal Protection Offered to Young Infants Completed NCT01698346 Phase 4
26 Regulatory Post-Marketing Surveillance (PMS) Study for TETRAXIM™(Combined Vaccine of Adsorbed Diphtheria, Tetanus, Acellular Pertussis and Enhanced Inactivated Poliomyelitis) Completed NCT01437423 Phase 4
27 Open Clinical Study to Assess the Immune Response and Safety of a Booster Dose (5th Dose) of a Combination Vaccine Against Diphteria-Tetanus-Pertussis-Polio Given to Healthy Adolescents 15-16 Years of Age. Completed NCT00514059 Phase 4 Boostrix polio
28 Evaluation of GSK Biologicals' dTpa Booster Vaccine in Adults, Given 10 Years After Previous dTpa Boosting. Completed NCT00548171 Phase 4
29 Immunogenicity and Safety Study of a Booster Dose of GSK Biologicals' Infanrix Hexa™ (217744) in Healthy Infants Born to Mothers Vaccinated With Boostrix™ During Pregnancy or Immediately Post-delivery Completed NCT02853929 Phase 4
30 A Phase IV, Single-blind, Randomized, Controlled, Monocentric Study to Assess the Interchangeability of Quinvaxem (DTwP-HepB-Hib) as the 2nd and 3rd Dose After Initial Vaccination With Tritanrix HB+Hib (DTwP-HepB/Hib) With Respect to Safety and Immunogenicity in Healthy Infants at 6, 10 and 14 Weeks of Age Completed NCT01357720 Phase 4
31 Safety and Immunogenicity of Adacel® Vaccine Administered to Persons 10 Years of Age Completed NCT01311557 Phase 4
32 A Prospective, Randomized, Open-label Clinical Trial to Assess the Safety and Immunogenicity of Simultaneous vs Sequential Administration of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine and Inactivated Influenza Vaccine in Pregnant Women - Pilot Completed NCT02783170 Phase 4
33 Safety and Immunogenicity of DAPTACEL® (CP10/5/5/3DT Aventis Pasteur 5-component Pertussis Vaccine in Combination With Tetanus and Diphtheria Toxoids Adsorbed) Administered as a 5th Dose in 4 to 6-Year-Old Children Previously Immunized With PENTACEL™ (HCP20/20/5/3DT-mIPV//PRP-T) Completed NCT00802867 Phase 4
34 Immunogenicity and Safety of Meningococcal (Groups A, C, Y, and W-135) Diphtheria Toxoid Conjugate Vaccine (Menactra®) in Adolescents in the US When Administered Concomitantly With Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine Adsorbed (Tdap Vaccine) Completed NCT00777257 Phase 4
35 Safety of the DTacP-IPV//PRP~T Combined Vaccine (PENTAXIM®) Given as a Three-Dose Primary Vaccination at 2, 3, and 4 Months of Age in Infants in China Completed NCT01491087 Phase 4
36 Phase IV, Open Label Trial to Evaluate Immunogenicity of Tdap Vaccine in Post-Partum Women to Optimize Vaccination Schedule for Women Who May Have a Subsequent Child Completed NCT01711645 Phase 4
37 Immunogenicity and Safety of the Diphtheria, Tetanus, Pertussis and Inactivated Poliovirus (DPT-IPV) Vaccine Squarekids Co-administered With GSK Biologicals' Human Rotavirus (HRV) Vaccine Rotarix (GSK444563) in Healthy Infants Completed NCT02907216 Phase 4
38 Safety & Immunogenicity of a Booster Dose of dTPa Vaccine (Boostrix®) Co-admnd. With Aventis Pasteur's Meningococcal (Serogroups A, C, Y and W-135) Polysaccharide Vaccine (Menactra™) vs Admn. of Either Vaccine Alone in Healthy Adolescents Completed NCT00282295 Phase 4
39 Immunogenicity and Safety Study of GSK Biologicals' Combined Diphtheria-tetanus-acellular Pertussis-hepatitis B-inactivated Polio-virus and Haemophilus Influenzae Type b Vaccine (Infanrix Hexa™) (217744) in Healthy Infants Born to Mothers Vaccinated With Boostrix™ During Pregnancy or Immediately Post-delivery Completed NCT02422264 Phase 4 Prevnar13
40 Immunogenicity and Safety of the Sanofi Pasteur's DTacP-IPV Combined Vaccine (TETRAXIM™) Given as a Booster Dose at 4 to 6 Years of Life in Children Previously Vaccinated With PENTAXIM™ in the Study E2I34 Completed NCT01031303 Phase 4
41 An Immunogenicity and Safety Evaluation of Menactra® (Meningococcal [Groups A, C, Y and W-135] Polysaccharide Diphtheria Toxoid Conjugate Vaccine) When Administered to Healthy Subjects at 9 Months and Concomitantly With Pentacel® at 15 to 18 Months of Age. Completed NCT01659996 Phase 4
42 Non-specific Effects of Vaccines - In Search of the Immunological Background Completed NCT00168545 Phase 4
43 A Phase IV Study to Evaluate the Primary and Booster Immune Responses of UK Infants Receiving a Licensed 6-in-1 DTaP/IPV/Hib/HBV Vaccine (Infanrix-HexaTM) With a 13-valent Pneumococcal Conjugate Vaccine and Incorporating a Randomisation Study of a Single Dose of 3 Different Meningococcal Group C Conjugate Vaccines at 3 Months of Age Completed NCT01896596 Phase 4
44 A Phase IV, Randomized Study to Evaluate the Immune Response of UK Infants Receiving DTaP/Hib/IPV, Meningococcal C Conjugate and Pneumococcal Conjugate Vaccines, Antibody Persistence and Responses to Booster Doses in the Second Year of Life Completed NCT00625677 Phase 4
45 Post-marketing, Randomized, Open-label Study to Assess the Immunogenicity and Safety of Concomitant Administration of V260 and Diphtheria, Tetanus, Pertussis and Inactivated Poliovirus Vaccine (DTP-IPV) in Japanese Healthy Infants Completed NCT01926015 Phase 4
46 Evaluation of GSK Biologicals' Boostrix™ Polio in Healthy Adults, 10 Years After a Booster Vaccination Completed NCT01323959 Phase 4
47 A Phase 4, Placebo-Controlled, Randomized Study to Evaluate the Immunogenicity and Safety of a Combined Tetanus, Reduced Diphtheria Toxoid, Acellular Pertussis Vaccine (Tdap, Boostrix®) and Quadrivalent Human Papillomavirus [Types 6, 11, 16, 18] Recombinant Vaccine (Gardasil®) in Healthy Adolescents When Administered With MenACWY Conjugate Vaccine Completed NCT01424644 Phase 4
48 A Phase 4, Randomized, Open-label Trial Evaluating the Safety, Tolerability, and Immunogenicity of DTaP Vaccine in Healthy Infants Given With a 7-valent Pneumococcal Conjugate Vaccine in Japan. Completed NCT01250756 Phase 4
49 An Open, Randomized, Multicenter Study of the Safety, Tolerability, and Immunogenicity of VAQTA™ Given Concomitantly With PedvaxHIB™ and Infanrix™ in Healthy Children 15 Months of Age Completed NCT00289913 Phase 4
50 A Phase IV (Not Interventional), Open-label, Multicentre Study to Evaluate the Reactogenicity and Safety of Co-administration of GlaxoSmithKline Biologicals' DTPa (Infanrix) and IPV (Poliorix) Vaccines Administered as Three-dose Primary Immunisation Course at 3, 4.5 and 6 Months of Age in Healthy Children in Russian Federation Completed NCT01094171 Phase 4

Search NIH Clinical Center for Pertussis

Inferred drug relations via UMLS 71 / NDF-RT 50 :


ERYTHROMYCIN PWDR
Guaifenesin

Cochrane evidence based reviews: bordetella infections

Genetic Tests for Pertussis

Anatomical Context for Pertussis

The Foundational Model of Anatomy Ontology organs/tissues related to Pertussis:

19
Respiratory Tract

MalaCards organs/tissues related to Pertussis:

40
Neutrophil, Smooth Muscle, Endothelial, Testes, T Cells, Brain, Lung

Publications for Pertussis

Articles related to Pertussis:

(showing 28476, show less)
# Title Authors PMID Year
1
Fever After Influenza, Diphtheria-Tetanus-Acellular Pertussis, and Pneumococcal Vaccinations. 61 42
32029684 2020
2
Licensure of a Diphtheria and Tetanus Toxoids and Acellular Pertussis, Inactivated Poliovirus, Haemophilus influenzae Type b Conjugate, and Hepatitis B Vaccine, and Guidance for Use in Infants. 61 42
32027629 2020
3
Use of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccines: Updated Recommendations of the Advisory Committee on Immunization Practices - United States, 2019. 61 42
31971933 2020
4
Coverage rates of the children vaccination programme in Greenland. 61
32000619 2020
5
Indole alkaloids from leaves of Alstonia scholaris (L.) R. Br. protect against emphysema in mice. 61
32387234 2020
6
Effectiveness of strategies to increase uptake of pertussis vaccination by new parents and family caregivers: A systematic review. 61
32470666 2020
7
Canonical and non-canonical Wnt signaling are simultaneously activated by Wnts in colon cancer cells. 61
32283254 2020
8
D-Peptide analogues of Boc-Phe-Leu-Phe-Leu-Phe-COOH induce neovascularization via endothelial N-formyl peptide receptor 3. 61
32152757 2020
9
SARS - CoV-2: Reasons of epidemiology of severe ill disease cases and therapeutic approach using trivalent vaccine (tetanus, diphtheria and Bordetella pertussis). 61
32387756 2020
10
Allele frequencies of Bordetella pertussis virulence-associated genes identified from pediatric patients with severe respiratory infections. 61
32334951 2020
11
Protective effects of pharmacological therapies in animal models of multiple sclerosis: a review of studies 2014-2019. 61
31960801 2020
12
A numerical efficient splitting method for the solution of two dimensional susceptible infected recovered epidemic model of whooping cough dynamics: Applications in bio-medical engineering. 61
32078958 2020
13
Modeling the waning and boosting of immunity from infection or vaccination. 61
32272134 2020
14
Control of vaccine preventable diseases in Australian infants: reviewing a decade of experience with DTPa-HBV-IPV/Hib vaccine. 61
32573398 2020
15
Involvement of Gi protein-dependent BKCa channel activation in β2-adrenoceptor-mediated dilation of retinal arterioles in rats. 61
32500188 2020
16
Association of weather variability with resurging pertussis infections among different age groups: A non-linear approach. 61
32135321 2020
17
Emergence of pertactin-deficient pertussis strains in Australia can be explained by models of vaccine escape. 61
32387895 2020
18
Rapid Diagnosis of a Family Cluster of Pertussis Starting from a Child: a Case Report. 61
32538045 2020
19
Efficiency of placental transfer of vaccine-elicited antibodies relative to prenatal Tdap vaccination status. 61
32482459 2020
20
Infant antibody levels following 10-valent pneumococcal-protein D conjugate and DTaP-Hib vaccinations in the first year of life after maternal Tdap vaccination: An open-label, parallel, randomised controlled trial. 61
32448624 2020
21
Extending Timing of Immunization Against Pertussis During Pregnancy and Protection of Premature Infants from Whooping Cough Disease. 61
32569371 2020
22
Whole-Cell Pertussis Vaccination and Decreased Risk of IgE-Mediated Food Allergy: A Nested Case-Control Study. 61
31891824 2020
23
The Law of Unintended Consequences in Pertussis Vaccination: An Ounce of Prevention, a Pound of Cure, and … Food Allergy? 61
32499040 2020
24
Quantity and Quality of Antibodies After Acellular Versus Whole-cell Pertussis Vaccines in Infants Born to Mothers Who Received Tetanus, Diphtheria, and Acellular Pertussis Vaccine During Pregnancy: A Randomized Trial. 61
31418814 2020
25
Paediatric Active Enhanced Disease Surveillance (PAEDS) 2017 and 2018: Prospective hospital-based surveillance for serious paediatric conditions. 61
32536339 2020
26
Delivering prenatal pertussis vaccine through maternity services in England: What is the impact on vaccine coverage? 61
32563605 2020
27
Review of pediatric encephalitis and encephalopathy cases following immunization reported to the Canadian Immunization Monitoring Program Active (IMPACT) from 1992 to 2012. 61
32414652 2020
28
Penta is associated with an increased female-male mortality ratio: cohort study from Bangladesh. 61
32573310 2020
29
Impact of state weights on national vaccination coverage estimates from household surveys in Nigeria. 61
32532542 2020
30
Can economic indicators predict infectious disease spread? A cross-country panel analysis of 13 European countries. 61
31291826 2020
31
Impact of extending the timing of maternal pertussis vaccination on hospitalized infant pertussis in England, 2014 - 2018. 61
32569365 2020
32
Per- and Polyfluoroalkyl Substances Differentially Inhibit Placental Trophoblast Migration and Invasion In Vitro. 61
32219433 2020
33
Influence of SOS-inducing agents on the expression of ArtAB toxin gene in Salmonella enterica and Salmonella bongori. 61
32579098 2020
34
Keep calm and carry on vaccinating: Is anti-vaccination sentiment contributing to declining vaccine coverage in England? 61
32561120 2020
35
Design of γ-AlOOH, γ-MnOOH, and α-Mn2O3 nanorods as advanced antibacterial active agents. 61
32543624 2020
36
Ensilicated tetanus antigen retains immunogenicity: in vivo study and time-resolved SAXS characterization. 61
32513957 2020
37
Barriers and drivers to adult vaccination among family physicians - Insights for tailoring the immunization program in Germany. 61
32409138 2020
38
Prevalence and predictors of taking tetanus toxoid vaccine in pregnancy: a cross-sectional study of 8,722 women in Sierra Leone. 61
32503478 2020
39
The short-chain free fatty acid receptor FFAR3 is expressed and potentiates contraction in human airway smooth muscle. 61
32209026 2020
40
Access, demand, and utilization of childhood immunization services: A cross-sectional household survey in Western Area Urban district, Sierra Leone, 2019. 61
32509292 2020
41
Timeliness of childhood vaccinations in Armenia, 2015-2016. 61
32448619 2020
42
Measuring the cellular memory B cell response after vaccination in patients after allogeneic stem cell transplantation. 61
32519092 2020
43
Oral cavity lesions as a manifestation of the novel virus (COVID-19): a letter-to-editor. 61
32510821 2020
44
Lysophosphatidic acid receptor-2 (LPA2)-mediated signaling enhances chemoresistance in melanoma cells treated with anticancer drugs. 61
32301060 2020
45
Pertussis in Lao PDR: Seroprevalence and disease. 61
32278108 2020
46
Analysis of Multiple Factors Involved in Pertussis-Like Coughing. 61
32075427 2020
47
Expression of small RNAs of Bordetella pertussis colonizing murine tracheas. 61
32227523 2020
48
Diphtheria, tetanus and pertussis: unequal vaccine siblings with distinct characteristics. 61
32516807 2020
49
Active SMS-based surveillance of adverse events following immunisation with influenza and pertussis-containing vaccines in Australian pregnant women using AusVaxSafety. 61
32499067 2020
50
Maternity staff immunization coverage against pertussis and maternal vaccination practices: Results of a 2017 cross-sectional survey in five public maternity hospitals. 61
31375373 2020
51
Access to skilled attendant at birth and the coverage of the third dose of diphtheria-tetanus-pertussis vaccine across 14 West African countries - an equity analysis. 61
32487158 2020
52
Feasibility and acceptability of the multi-component P3-MumBubVax antenatal intervention to promote maternal and childhood vaccination: A pilot study. 61
32321684 2020
53
Development of a targeted nanoLC-MS/MS method for quantitation of residual toxins from Bordetella pertussis. 61
32526622 2020
54
An Investigation of Japanese Neonatal and Maternal Antibody Status against Pertussis. 61
32009055 2020
55
Identification of the minimum region of Bordetella pertussis Vag8 required for interaction with C1 inhibitor. 61
32396237 2020
56
Combined RNAseq and ChIPseq Analyses of the BvgA Virulence Regulator of Bordetella pertussis. 61
32430408 2020
57
Seroprevalence of antibodies against diphtheria, tetanus, and pertussis among healthy Thai adolescents. 61
32387447 2020
58
Live attenuated pertussis vaccine BPZE1 induces a broad antibody response in humans. 61
31945015 2020
59
Effectiveness of rapid multiplex polymerase chain reaction for early diagnosis and treatment of pertussis. 61
32513618 2020
60
Urgent Bordetella PCR in infants under 3 months, a useful tool in the Pediatric Emergency Department. 61
32471689 2020
61
Increasing adult vaccinations at a regional supermarket chain pharmacy: A multi-site demonstration project. 61
32093985 2020
62
Assessment of IgA anti-PT and IgG anti-ACT reflex testing to improve Bordetella pertussis serodiagnosis in recently vaccinated subjects. 61
31610300 2020
63
Knowledge and acceptance of influenza and pertussis vaccinations among pregnant women of low socioeconomic status in Turkey. 61
31687874 2020
64
Metabolic profile of alkaloids in Rhizoma Coptidis in rat plasma, urine and feces after oral administration using ultra-high-performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry. 61
32077179 2020
65
Prenatal tetanus, diphtheria, acellular pertussis vaccination and attention deficit hyperactivity disorder. 61
32378703 2020
66
Functional characterization of 5-HT1A and 5-HT1B serotonin receptor signaling through G-protein-activated inwardly rectifying K+ channels in a fluorescence-based membrane potential assay. 61
32088264 2020
67
Development and Characterization of an Allergic Asthma Rat Model for Interventional Studies. 61
32481675 2020
68
[Access to complementary tests for the diagnosis of infectious diseases in primary care paediatric clinics]. 61
32430217 2020
69
Role of PKCζ-NADPH oxidase signaling axis in PKCα-mediated Giα2 phosphorylation for inhibition of adenylate cyclase activity by angiotensin II in pulmonary artery smooth muscle cells. 61
31965656 2020
70
Irreversible versus repairable membrane poration: differences in permeabilization elicited by Bordetella Adenylate Cyclase Toxin and its hemolysin domain in macrophages. 61
31652486 2020
71
Acyltransferase-mediated selection of the length of the fatty acyl chain and of the acylation site governs activation of bacterial RTX toxins. 61
32461253 2020
72
Multiple weak interactions between BvgA~P and ptx promoter DNA strongly activate transcription of pertussis toxin genes in Bordetella pertussis. 61
32401811 2020
73
Tetanus, diphtheria and acellular pertussis (Tdap) vaccine for prevention of pertussis among adults aged 19 years and older in the United States: A cost-effectiveness analysis. 61
32199910 2020
74
Dynamical footprints enable detection of disease emergence. 61
32433658 2020
75
Antibodies to measles, mumps, and rubella virus in Thai children after two-dose vaccination at 9 months and 2.5 years: A longitudinal study. 61
32331806 2020
76
Seroprevalences of antibodies against pertussis, diphtheria, tetanus, measles, mumps and rubella: A cross-sectional study in children following vaccination procedure in Guangzhou, China. 61
32321685 2020
77
Infant vaccine co-administration: review of 18 years of experience with GSK's hexavalent vaccine co-administered with routine childhood vaccines. 61
32419537 2020
78
Knowledge and Attitude towards Vaccination among Healthcare Workers: A Multicenter Cross-Sectional Study in a Southern Italian Region. 61
32456273 2020
79
Estimation of the wastage rate of MMR and pentavalent vaccines in open and closed vials in three western provinces of Iran. 61
32462097 2020
80
Applying a Constrained Optimization Portfolio Model to Aid Prioritization of Public Health Interventions in Malaysia. 61
32044690 2020
81
Socioeconomic inequality trends in childhood vaccination coverage in India: Findings from multiple rounds of National Family Health Survey. 61
32362524 2020
82
Putative mGluR4 positive allosteric modulators activate Gi-independent anti-inflammatory mechanisms in microglia. 61
32454165 2020
83
Efficacy and Safety of Revaccination against Tetanus, Diphtheria, Haemophilus influenzae Type b and Hepatitis B Virus in a Prospective Cohort of Adult Recipients of Allogeneic Hematopoietic Stem Cell Transplantation. 61
32428736 2020
84
Comparative genomics of whole-cell pertussis vaccine strains from India. 61
32381023 2020
85
Transmission of respiratory tract infections at mass gathering events. 61
32149751 2020
86
Acellular Pertussis Vaccine Components: Today and Tomorrow. 61
32414005 2020
87
Pertussis in adults: which vaccine? 61
32266369 2020
88
Pertussis vaccination in mixed markets: Recommendations from the Global Pertussis Initiative. 61
32413606 2020
89
Transcriptional profiling of human macrophages during infection with Bordetella pertussis. 61
32070192 2020
90
Pathogen analysis of pertussis-like syndrome in children. 61
32429853 2020
91
Pertussis vaccination and Allergic illness in Australian children. 61
32459867 2020
92
Epidemiology of Bordetella pertussis Among Patients With Cancer. 61
31504316 2020
93
A call for caution in use of pertussis vaccine effectiveness studies to estimate waning immunity: A Canadian Immunization Research Network Study. 61
32384142 2020
94
Uncovering Distinct Primary Vaccination-Dependent Profiles in Human Bordetella Pertussis Specific CD4+ T-Cell Responses Using a Novel Whole Blood Assay. 61
32429152 2020
95
High prevalence of Bordetella pertussis in young hospitalized infants with acute respiratory infection in the south of China: age- and season-dependent effects. 61
31981637 2020
96
Highlights of the 12th International Bordetella Symposium. 61
32463883 2020
97
Leukotriene B4 Receptor Type 2 Accelerates the Healing of Intestinal Lesions by Promoting Epithelial Cell Proliferation. 61
31941716 2020
98
The first report of isolation of macrolide-resistant Bordetella pertussis in Japan. 61
32350216 2020
99
Discovery of Compounds Inhibiting the ADP-Ribosyltransferase Activity of Pertussis Toxin. 61
31899865 2020
100
High healthcare resource utilisation due to pertussis in Australian adults aged 65 years and over. 61
32220516 2020
101
Perinatal health care providers' approaches to recommending and providing pertussis vaccination in pregnancy: a qualitative study. 61
32414884 2020
102
Hepatitis B and pertussis antibodies in 4- to 5-year-old children previously vaccinated with different hexavalent vaccines. 61
31689166 2020
103
Immuno-proteomics analysis between OMV of vaccine and dominant wild type strains of Bordetella pertussis in Iran. 61
32494341 2020
104
Chemical Synthesis and Immunological Evaluation of a Pentasaccharide Bearing Multiple Rare Sugars as a Potential Anti-pertussis Vaccine. 61
31953912 2020
105
ADVANCE system testing: Estimating the incidence of adverse events following pertussis vaccination in healthcare databases with incomplete exposure data. 61
32280043 2020
106
Barriers and facilitators regarding influenza and pertussis maternal vaccination uptake: A multi-center survey of pregnant women in Italy. 61
32044622 2020
107
Intranasal immunization with outer membrane vesicle pertussis vaccine confers broad protection through mucosal IgA and Th17 responses. 61
32355188 2020
108
Differential activation of G protein-mediated signaling by synthetic cannabinoid receptor agonists. 61
32101383 2020
109
Efficacy of a Protein Vaccine and a Conjugate Vaccine Against Co-colonization with Vaccine-type and Non-vaccine Type Pneumococci in Mice. 61
32290340 2020
110
Quantification of the sensitivity of early detection surveillance. 61
32337798 2020
111
Vaccines are underused in pregnancy: what about knowledge, attitudes and practices of providers? 61
32275268 2020
112
Vaccination coverage of general practitioners: a cross-sectional study from Greece. 61
32000009 2020
113
Mechanistic insights into δ-opioid-induced cardioprotection: Involvement of caveolin translocation to the mitochondria. 61
31715185 2020
114
Vaccination during pregnancy: Canadian maternity care providers' opinions and practices. 61
32271655 2020
115
Multicenter Evaluation of the QIAstat-Dx Respiratory Panel for Detection of Viruses and Bacteria in Nasopharyngeal Swab Specimens. 61
32132186 2020
116
Public health strategies adopted to manage the increase of accesses to vaccination services, as a result of the application of the law 119/2017. 61
32275265 2020
117
Emerging Topics in Vaccine Therapeutics for Adolescents and Adults: An Update for Immunizing Pharmacists. 61
30352534 2020
118
Is there an association between socioeconomic status and immune response to infant and childhood vaccination in the Netherlands? 61
32063433 2020
119
Uncovering molecular targets for regenerative therapy in degenerative disc disease: do small Leucine-Rich proteoglycans hold the key? 61
32344061 2020
120
Age-Dependent Effects of Type I and Type III IFNs in the Pathogenesis of Bordetella pertussis Infection and Disease. 61
32152071 2020
121
Homogeneous Dual-Parametric-Coupled Assay for Simultaneous Nucleotide Exchange and KRAS/RAF-RBD Interaction Monitoring. 61
32106676 2020
122
Social capital and utilization of immunization service: A multilevel analysis in rural Uttar Pradesh, India. 61
32405528 2020
123
Investigation on Ciliary Functionality of Different Airway Epithelial Cell Lines in Three-Dimensional Cell Culture. 61
31696788 2020
124
Antidepressants induce profibrotic responses via the lysophosphatidic acid receptor LPA1. 61
32007501 2020
125
A Phase II, randomized, immunogenicity and safety study of a quadrivalent meningococcal conjugate vaccine, MenACYW-TT, in healthy adolescents in the United States. 61
32209248 2020
126
Early Leukapheresis Depletion in an Ex-Premature with Severe Acute Respiratory Distress Syndrome Due to Bordetella Pertussis and Coronavirus Infection. 61
32340021 2020
127
Antibiotic Use Associated with Confirmed Influenza, Pertussis, and Nontyphoidal Salmonella Infections. 61
32315565 2020
128
[Coverage rate and adverse reactions of National Immunization Program vaccines in children with spinal muscular atrophy: a cross-sectional retrospective cohort study]. 61
32234138 2020
129
Clinical characteristics, molecular epidemiology and antimicrobial susceptibility of pertussis among children in southern China. 61
31493136 2020
130
Pertussis in high-risk groups: an overview of the past quarter-century. 61
32298213 2020
131
Psychosocial determinants of pertussis and influenza vaccine uptake in pregnant women: A prospective study. 61
32070678 2020
132
Incidence rates of health outcomes of interest among Chinese children exposed to selected vaccines in Yinzhou Electronic Health Records: A population-based retrospective cohort study. 61
32178909 2020
133
Talk to Patients About: Cleanliness vs. Vaccines. 61
32353155 2020
134
Dynamics of pertussis toxin IgG after symptomatic pertussis in children and adults. 61
32171577 2020
135
Burden of Children Hospitalized With Pertussis in Canada in the Acellular Pertussis Vaccine Era, 1999-2015. 61
30535079 2020
136
[Introduction of pertussis vaccination during pregnancy]. 61
32392010 2020
137
Intracellular acidification facilitates receptor-operated TRPC4 activation through PLCδ1 in a Ca2+ -dependent manner. 61
32338378 2020
138
Valuing the cost of improving Chilean primary vaccination: a cost minimization analysis of a hexavalent vaccine. 61
32272920 2020
139
Different perspectives of immunizations during pregnancy 61
31905497 2020
140
A highly sensitive one-tube nested quantitative real-time PCR assay for specific detection of Bordetella pertussis using the LNA technique. 61
32045697 2020
141
Immune interference (blunting) in the context of maternal immunization with Tdap-containing vaccines: is it a class effect? 61
32237928 2020
142
Antenatal vaccine uptake: A cross-sectional study investigating factors influencing women's choices in pregnancy. 61
32207153 2020
143
Tdap vaccination during pregnancy interrupts a twenty-year increase in the incidence of pertussis. 61
32070682 2020
144
Multiplex Point-of-Care Tests for the Determination of Antibodies after Acellular Pertussis Vaccination. 61
32230963 2020
145
Optimization of sample preparation for culture-independent sequencing of Bordetella pertussis. 61
32108565 2020
146
Clinical Profile of Critical Pertussis in Children at a Pediatric Intensive Care Unit in Northern India. 61
32198862 2020
147
Pertussis epidemiology and effect of vaccination among diagnosed children at Vietnam, 2015-2018. 61
32181924 2020
148
Abundance of the nasopharyngeal microbiome effects pertussis diagnosis and explains the sensitivity difference between bacterial culture and real-time PCR. 61
31797154 2020
149
Tetanus, diphtheria, and pertussis vaccine (Tdap) in pregnancy and risk of major birth defects in the offspring. 61
31903700 2020
150
Membrane Activity and Channel Formation of the Adenylate Cyclase Toxin (CyaA) of Bordetella pertussis in Lipid Bilayer Membranes. 61
32164365 2020
151
Bordetella pertussis induces IFN-γ production by NK cells resulting in chemo-attraction by respiratory epithelial cells. 61
32219323 2020
152
Critical Signaling Events in the Mechanoactivation of Human Mast Cells through p.C492Y-ADGRE2. 61
32222457 2020
153
Bitter taste receptors stimulate phagocytosis in human macrophages through calcium, nitric oxide, and cyclic-GMP signaling. 61
32172302 2020
154
Using the North Dakota IIS to Assess the Response of Health Care Providers to the ACIP Recommendation for Tdap Vaccination During Pregnancy. 61
31834203 2020
155
A Novel Reporter Gene Assay for Pyrogen Detection. 61
31666494 2020
156
Burden-of-illness vaccine efficacy. 61
32220002 2020
157
A Qualitative Study of Views and Experiences of Women and Health Care Professionals about Free Maternal Vaccinations Administered at Community Pharmacies. 61
32235360 2020
158
Midwives' role in the provision of maternal and childhood immunisation information. 61
30853352 2020
159
Maraviroc attenuates the pathogenesis of experimental autoimmune encephalitis. 61
32007705 2020
160
Factors affecting pregnant women's decisions regarding prenatal pertussis vaccination: A decision-making study in the nationwide Prenatal Pertussis Immunization Program in Taiwan. 61
32127138 2020
161
Seroprevalence of Bordetella pertussis antibodies and anti-pertussis antibody response after a single dose of reduced-antigen combined diphtheria, tetanus, and acellular pertussis vaccine (Tdap) in pregnant Thai women. 61
32070680 2020
162
A Nationwide Survey on the Hospital Vaccination Policies in Korea. 61
32233157 2020
163
Bacterial, viral, and fungal infection-related risk of Parkinson's disease: Meta-analysis of cohort and case-control studies. 61
32017453 2020
164
Adult Vaccination Rates in the Mentally Ill Population: An Outpatient Improvement Project. 61
30866701 2020
165
Factors associated with referring close contacts to an app with individually-tailored vaccine information. 61
32098739 2020
166
Order of Live and Inactivated Vaccines and Risk of Non-vaccine-targeted Infections in US Children 11-23 Months of Age. 61
32032310 2020
167
The adult vaccination landscape in the United States during the Affordable Care Act era: Results from a large retrospective database analysis. 61
32115298 2020
168
Are all vaccines safe for the pregnant traveller? A systematic review and meta-analysis. 61
31616947 2020
169
Double rarity: an unusual case of bromoform poisoning detected by post-mortem radiography. 61
30848339 2020
170
Congenital nephrotic syndrome secondary to pertussis. 61
31160052 2020
171
Bordetella pertussis Infection Presenting as Chronic Cough. 61
30943807 2020
172
Prevalence of B. pertussis infection in children with clinically suspected pertussis. 61
32245724 2020
173
School Exclusions During Selected Pertussis Outbreaks, Oregon, 2017-2018. 61
32227187 2020
174
Pertussis immunization in healthcare workers working in pediatric settings: Knowledge, Attitudes and Practices (KAP) of Occupational Physicians. Preliminary results from a web-based survey (2017). 61
32490271 2020
175
Out-of-sequence vaccinations with measles vaccine and diphtheria-tetanus-pertussis vaccine. A re-analysis of demographic surveillance data from rural Bangladesh. 61
32185375 2020
176
Corrigendum to 'Antibody persistence and safety and immunogenicity of a second booster dose nine years after a first booster vaccination with a reduced antigen diphtheria-tetanus-acellular pertussis vaccine (Tdap) in adults'. [Vaccine 36 (2018) 6325-6333]. 61
32061383 2020
177
Bordetella Dermonecrotic Toxin Is a Neurotropic Virulence Factor That Uses CaV3.1 as the Cell Surface Receptor. 61
32209694 2020
178
Mandatory Vaccination in Europe. 61
31932361 2020
179
Immunogenicity and safety of a combined DTPa-IPV/Hib vaccine administered as a three-dose primary vaccination course and a booster dose in healthy children in Russia: a phase III, non-randomized, open-label study. 61
32048889 2020
180
Factors associated with Tdap vaccination receipt during pregnancy: a cross-sectional study. 61
31726399 2020
181
Genome diversity and evolutionary characteristics of clinical isolates of Bordetella pertussis circulating in Iran. 61
32322373 2020
182
A novel method for the extraction of outer membrane vesicles (OMVs) from Bordetella pertussis Tohama strain. 61
32322378 2020
183
Evaluation of immunisation strategies for pertussis vaccines in Jinan, China - an interrupted time-series study. 61
32046804 2020
184
Structural and Functional Characterization of the Globin-Coupled Sensors of Azotobacter vinelandii and Bordetella pertussis. 61
31559835 2020
185
Assessing adolescent immunization options for pertussis in Canada: A cost-utility analysis. 61
31889607 2020
186
Dose-dependent effectiveness of acellular pertussis vaccine in infants: A population-based case-control study. 61
31813648 2020
187
Timeliness and equity of infant pertussis vaccination in wales: Analysis of the three dose primary course. 61
31839466 2020
188
Impact of Pertussis on the Italian population: Analysis of hospital discharge records in the period 2001-2014. 61
31678191 2020
189
Infant hospitalisations and fatalities averted by the maternal pertussis vaccination programme in England, 2012-2017: Post-implementation economic evaluation. 61
32095810 2020
190
Update from the Advisory Committee on Immunization Practices. 61
32016424 2020
191
Safety and effectiveness of acellular pertussis vaccination during pregnancy: a systematic review. 61
32054444 2020
192
Congenital nephrotic syndrome as a complication of whooping cough: a case report. 61
32128219 2020
193
Beneficial role of simvastatin in experimental autoimmune myositis. 61
31863923 2020
194
Two centuries of immunisation in the UK (part 1). 61
31272966 2020
195
Routine Childhood Vaccines Given in the First 11 Months of Life. 61
31879133 2020
196
Role of lysophosphatidic acid in vascular smooth muscle cell proliferation. 61
31369714 2020
197
Exploring bacterial pathogen community dynamics in freshwater beach sediments: A tale of two lakes. 61
31736260 2020
198
Immunogenicity, transplacental transfer of pertussis antibodies and safety following pertussis immunization during pregnancy: Evidence from a randomized, placebo-controlled trial. 61
31776029 2020
199
Coverage rates and timeliness of nationally recommended vaccinations in Swiss preschool children: A descriptive analysis using claims data. 61
31791812 2020
200
How are children who are delayed in the Childhood Vaccination Programme vaccinated: A nationwide register-based cohort study of Danish children aged 15-24 months and semi-structured interviews with vaccination providers. 61
30024308 2020
201
Revisiting Role of Vaccinations in Donors, Transplant Recipients, Immunocompromised Hosts, Travelers, and Household Contacts of Stem Cell Transplant Recipients. 61
31682981 2020
202
Hepatitis B Birth Dose Effects on Childhood Immunization in the U.S. 61
31959321 2020
203
Safety of tetanus, diphtheria, and acellular pertussis vaccination among pregnant active duty U.S. military women. 61
31952872 2020
204
Functionally Selective Inhibition of the Oxytocin Receptor by Retosiban in Human Myometrial Smooth Muscle. 61
31907536 2020
205
Comparison of hepatitis B surface antibody levels induced by the pentavalent DTwP-HB-Hib versus the hexavalent DTaP-HB-Hib-IPV vaccine, administered to infants at 2, 4, 6, and 18 months of age, following monovalent hepatitis B vaccination at birth. 61
31948817 2020
206
Prevention of chronic diseases in middle-age women: a cross-sectional study on an Italian large sample. 61
31263891 2020
207
Impact of mother's education on full immunization of children aged 12-23 months in Eritrea: population and health survey 2010 data analysis. 61
32087706 2020
208
What Matters to Parents Regarding Immunization of Their Children: Systematic Analysis of Expert Advice to Parents in an Internet Forum. 61
31725113 2020
209
Temporally Coarse-Grained All-Atom Molecular Dynamics Achieved via Stochastic Padé Approximants. 61
31958947 2020
210
Expression and function of umami receptors T1R1/T1R3 in gastric smooth muscle. 61
31721379 2020
211
A cost-effectiveness analysis of traditional and geographic information system-supported microplanning approaches for routine immunization program management in northern Nigeria. 61
31924428 2020
212
Childhood infectious diseases and risk of non-Hodgkin's lymphoma according to the WHO classification: A reanalysis of the Italian multicenter case-control study. 61
31077355 2020
213
Waning vaccine immunity and vaccination responses in children treated for acute lymphoblastic leukemia: A Canadian Immunization Research Network Study. 61
32067048 2020
214
π-Helix controls activity of oxygen-sensing diguanylate cyclases. 61
32039439 2020
215
Neutralization of pertussis toxin by a single antibody prevents clinical pertussis in neonatal baboons. 61
32076653 2020
216
[Progress in etiology, pathogenesis and clinical characteristics of pertussis syndrome]. 61
32102158 2020
217
Vaccination during pregnancy: current and possible future recommendations. 61
31912233 2020
218
Impact in children under the age of one of Tdap vaccination programme on pregnant women in Castelló. 61
32057550 2020
219
Development of a Pertactin-Coated Beads Approach for Screening of Functional Monoclonal Antibodies. 61
31589874 2020
220
Impact of tetanus-diphtheria-acellular pertussis immunization during pregnancy on subsequent infant immunization seroresponses: follow-up from a large randomized placebo-controlled trial. 61
31776027 2020
221
ADVANCE database characterisation and fit for purpose assessment for multi-country studies on the coverage, benefits and risks of pertussis vaccinations. 61
32061385 2020
222
Safety review of tetanus toxoid, reduced diphtheria toxoid, acellular pertussis vaccines (Tdap) in adults aged ≥65 years, Vaccine Adverse Event reporting System (VAERS), United States, September 2010-December 2018. 61
31883809 2020
223
HIV-1 Tat protein attenuates the clinical course of experimental autoimmune encephalomyelitis (EAE). 61
31830622 2020
224
Thyrotropin Causes Dose-dependent Biphasic Regulation of cAMP Production Mediated by Gs and Gi/o Proteins. 61
31704717 2020
225
Comparative Clinical Evaluation of NeoPlex RB-8 with Seeplex PneumoBacter ACE for Simultaneous Detection of Eight Respiratory Bacterial Pathogens. 61
31748320 2020
226
Investigation of the effects of oxidative stress-inducing factors on culturing and productivity of Bordetella pertussis. 61
31483095 2020
227
Using big data to predict pertussis infections in Jinan city, China: a time series analysis. 61
31478106 2020
228
Selective protection of murine cerebral Gi/o-proteins from inactivation by parenterally injected pertussis toxin. 61
31811326 2020
229
Surfaceome analysis of Australian epidemic Bordetella pertussis reveals potential vaccine antigens. 61
31703933 2020
230
Pertussis epidemiological pattern and disease burden in Brazil: an analysis of national public health surveillance data. 61
31242082 2020
231
Spatio-temporal analysis of Pertussis using geographic information system among Iranian population during 2012-2018. 61
32551311 2020
232
Hfq modulates global protein pattern and stress response in Bordetella pertussis. 61
31669358 2020
233
[Pertussis in Newborns and Infants - Can an Increase in Number of Cases and Deaths be Prevented?] 61
31569260 2020
234
Questionnaire survey on maternal pertussis vaccination for pregnant women and mothers in Nara prefecture, Japan. 61
31368853 2020
235
In silico identification and modification of T cell epitopes in pertussis antigens associated with tolerance. 61
31951773 2020
236
Development and Standardization of a High-Throughput Bordetella pertussis Growth-Inhibition Assay. 61
32425912 2020
237
Development and Validation of a Bordetella pertussis Whole-Genome Screening Strategy. 61
32322598 2020
238
Impact of maternal dTpa vaccination on the incidence of pertussis in young infants. 61
31990945 2020
239
Determining Factors for Pertussis Vaccination Policy: A Study in Five EU Countries. 61
31991855 2020
240
Functional and structural consequences of epithelial cell invasion by Bordetella pertussis adenylate cyclase toxin. 61
32392246 2020
241
A qPCR assay for Bordetella pertussis cells that enumerates both live and dead bacteria. 61
32353041 2020
242
Pertussis in infants, in their mothers and other contacts in Casablanca, Morocco. 61
31937256 2020
243
Two important problems in terms of child health: pertussis and obesity. 61
32231443 2020
244
Influenza and pertussis vaccination of women during pregnancy in Victoria, 2015-2017. 61
31763697 2020
245
Asymptomatic Infection and Transmission of Pertussis in Households: A Systematic Review. 61
31257450 2020
246
[Studying the possibility of using immuno-enzy test system for evaluating anti-pertussis immunity.] 61
32159305 2020
247
Variation in Tdap and Influenza Vaccination Coverage Among Pregnant Women by Insurance Type - Florida, 2016-2018. 61
31971934 2020
248
Tetanus, Diphtheria, and Acellular Pertussis and Influenza Vaccinations among Women With a Live Birth, Internet Panel Survey, 2017-2018. 61
32095076 2020
249
Factors Affecting the Implementation Process of Pertussis [Tdap] Immunization in Pregnant Women in an Italian Region: A Qualitative Study. 61
32426313 2020
250
A multi-country, multi-year, meta-analytic evaluation of the sex differences in age-specific pertussis incidence rates. 61
32324790 2020
251
Adverse event occurrence following use of tetanus, diphtheria and acellular pertussis adsorbed vaccine - Tdap -, São Paulo, SP, Brazil, 2015-2016. 61
32401912 2020
252
Interacting, Nonspecific, Immunological Effects of Bacille Calmette-Guérin and Tetanus-diphtheria-pertussis Inactivated Polio Vaccinations: An Explorative, Randomized Trial. 61
30919883 2020
253
Evaluation of inactivated Bordetella pertussis as a delivery system for the immunization of mice with Pneumococcal Surface Antigen A. 61
31945121 2020
254
Correction: Evaluation of inactivated Bordetella pertussis as a delivery system for the immunization of mice with Pneumococcal Surface Antigen A. 61
32023329 2020
255
Cost-effectiveness analysis of universal adult immunization with tetanus-diphtheria-acellular pertussis vaccine (Tdap) versus current practice in Brazil. 61
31648911 2020
256
Highly accurate-single chromosomal complete genomes using IonTorrent and MinION sequencing of clinical pathogens. 61
30978388 2020
257
Private sector vaccine share in overall immunization coverage in India: Evidence from private sector vaccine utilization data (2012-2015). 61
32189688 2020
258
Safety, equity and monitoring: a review of the gaps in maternal vaccination strategies for Aboriginal and Torres Strait Islander women. 61
31368832 2020
259
Infections, Vaccines and Autoimmunity: A Multiple Sclerosis Perspective. 61
32012815 2020
260
Multicenter evaluation of the QIAstat Respiratory Panel-A new rapid highly multiplexed PCR based assay for diagnosis of acute respiratory tract infections. 61
32163484 2020
261
Advances in Vaccines. 61
31446443 2020
262
G Protein-Coupling of Adhesion GPCRs ADGRE2/EMR2 and ADGRE5/CD97, and Activation of G Protein Signalling by an Anti-EMR2 Antibody. 61
31969668 2020
263
Current situation, causes, and countermeasures to NIP vaccine shortages in Guangzhou, China. 61
31403888 2020
264
[Measles]. 61
32282323 2020
265
The Lacritin-Syndecan-1-Heparanase Axis in Dry Eye Disease. 61
32274735 2020
266
TSH Receptor Homodimerization in Regulation of cAMP Production in Human Thyrocytes in vitro. 61
32425890 2020
267
Impact of the adolescent pertussis booster dose on the incidence of pertussis in British Columbia and Quebec, Canada. 61
31685295 2020
268
National Outbreak of Pertussis in England, 2011-2012: A Case-control Study Comparing 3-Component and 5-Component Acellular Vaccines With Whole-cell Pertussis Vaccines. 61
31059566 2020
269
Maternal Vaccination in Argentina: Tetanus, Diphtheria, and Acellular Pertussis Vaccine Effectiveness During Pregnancy in Preventing Pertussis in Infants <2 Months of Age. 61
30877308 2020
270
Anti-NMDA Receptor Encephalitis, Vaccination and Virus. 61
31820697 2020
271
Vaccination Programs for Adults in Europe, 2019. 61
31968652 2020
272
Vertically Transferred Immunity in Neonates: Mothers, Mechanisms and Mediators. 61
32296443 2020
273
CD8 T-cell Recruitment Into the Central Nervous System of Cuprizone-Fed Mice: Relevance to Modeling the Etiology of Multiple Sclerosis. 61
32210765 2020
274
Family Health Days program contributions in vaccination of unreached and under-immunized children during routine vaccinations in Uganda. 61
31951608 2020
275
Differential effect of adenosine on rhabdomyosarcoma migration and proliferation. 61
32190153 2020
276
Progress towards measles elimination in Eritrea: 2003 - 2018. 61
32373258 2020
277
Women, children and adolescents in conflict countries: an assessment of inequalities in intervention coverage and survival. 61
32133179 2020
278
CR4056, a powerful analgesic imidazoline-2 receptor ligand, inhibits the inflammation-induced PKCε phosphorylation and membrane translocation in sensory neurons. 61
31454418 2020
279
Vaccine coverage within the first year of life and associated factors with incomplete immunization in a Brazilian birth cohort. 61
32292586 2020
280
Long-term immunogenicity and immune memory response to the hepatitis B antigen in the RTS,S/AS01E malaria vaccine in African children: a randomized trial. 61
31951771 2020
281
Midwives' knowledge, attitudes and confidence in discussing maternal and childhood immunisation with parents: A national study. 61
31628030 2020
282
The clinical characteristics and prognosis of pertussis among unvaccinated infants in the pediatric intensive care unit. 61
32231450 2020
283
Engineering of an Iranian Bordetella pertussis strain producing inactive pertussis toxin. 61
31778110 2020
284
Sensitized heat shock protein 27 induces retinal ganglion cells apoptosis in rat glaucoma model. 61
32399401 2020
285
Synaptic alterations and immune response are sexually dimorphic in a non-pertussis toxin model of experimental autoimmune encephalomyelitis. 61
31499065 2020
286
The unmet need for pertussis prevention in patients with chronic obstructive pulmonary disease in the Italian context. 61
31403385 2020
287
Relevance of the Materno-Fetal Interface for the Induction of Antigen-Specific Immune Tolerance. 61
32477339 2020
288
Diphteria-tetanus-pertussis vaccine reduces specific IgE, inflammation and remodelling in an animal model of mite-induced respiratory allergy. 61
31630941 2020
289
Vaccination of Adults and the Older Population against Tetanus, Diphtheria, Pertussis, and Tick-Borne Encephalitis: The Importance of Booster Vaccinations throughout Life. 61
32305971 2020
290
Pertussis vaccines: The first hundred years. 61
31780181 2020
291
How Important Is the Type of Acellular Pertussis Vaccine? 61
31059563 2020
292
Identification of novel phytocannabinoids from Ganoderma by label-free dynamic mass redistribution assay. 61
31494202 2020
293
Improving vaccination uptake among adolescents. 61
31978259 2020
294
Vaccination of Adults in General Medical Practice. 61
31902413 2020
295
Pregnancy has a minimal impact on the acute transcriptional signature to vaccination. 61
32219001 2020
296
Use of a Neonatal-Mouse Model to Characterize Vaccines and Strategies for Overcoming the High Susceptibility and Severity of Pertussis in Early Life. 61
32362890 2020
297
Epidemiology and disease burden of pertussis in the United States among individuals aged 0-64 over a 10-year period (2006-2015). 61
31491361 2020
298
Economic impact of implementing decennial tetanus toxoid, reduced diphtheria toxoid and acellular pertussis (Tdap) vaccination in adults in the United States. 61
31676198 2020
299
An infant who suffered seizures many times after pentavalent vaccination: A case report. 61
32478306 2020
300
The trend of full vaccination coverage in infants and inequalities by wealth quintile and maternal education: analysis from four recent demographic and health surveys in Nepal. 61
31830944 2019
301
[Vaccine loss related to the expanded immunization program in Xinjiang Uygur Autonomous Region, 2016-2017]. 61
32062921 2019
302
Routine immunizations during pregnancy, doctors' compliance and patient hesitancy: A two stage study on vaccination uptake. 61
31671289 2019
303
Bordet-Gengou agar medium supplemented with albumin-containing biologics for cultivation of bordetellae. 61
31489969 2019
304
Evaluating the role of cough duration in the pertussis case definition among Michigan cases, 2000-2010. 61
31485391 2019
305
Immunological and Clinical Benefits of Maternal Immunization Against Pertussis: A Systematic Review. 61
31535327 2019
306
The maternal antibody against diphtheria, tetanus and pertussis showed distinct regional difference in China. 61
31810436 2019
307
Trends in Infant Pertussis Hospitalizations in the United States, 2009-2017. 61
31794618 2019
308
Tracking U.S. Pertussis Incidence: Correlation of Public Health Surveillance and Google Search Data Varies by State. 61
31875051 2019
309
Structure and membrane-targeting of a Bordetella pertussis effector N-terminal domain. 61
31487494 2019
310
Pertussis seronegativity in pregnant women in the city of Al Ain, United Arab Emirates. 61
31493522 2019
311
RE: 'Vaccination against pertussis and influenza in pregnancy: a qualitative study of barriers and facilitators'. 61
31084946 2019
312
Designing a new multi-epitope pertussis vaccine with highly population coverage based on a novel sequence and structural filtration algorithm. 61
31831431 2019
313
Vaccine-driven virulence evolution: consequences of unbalanced reductions in mortality and transmission and implications for pertussis vaccines. 61
31822219 2019
314
Further investigations of the IgE response to tetanus and diphtheria following covaccination with acellular rather than cellular Bordetella pertussis. 61
31419322 2019
315
Case report of massive hemoptysis in pregnancy requiring veno-venous extracorporeal membrane oxygenation. 61
31486147 2019
316
Knowledge, perception and maternal immunisation practices of obstetricians in Singapore for the Tdap and influenza vaccines. 61
31820007 2019
317
[Dramatic achievements in infectious disease prevention and treatment in China during the past 70 years]. 61
32062906 2019
318
Cannabichromene is a cannabinoid CB2 receptor agonist. 61
31368508 2019
319
RTX Toxins Ambush Immunity's First Cellular Responders. 61
31835552 2019
320
C‑type natriuretic peptide prevents angiotensin II‑induced atrial connexin 40 and 43 dysregulation by activating AMP‑activated kinase signaling. 61
31638216 2019
321
Selection bias introduced by informative censoring in studies examining effects of vaccination in infancy. 61
31071211 2019
322
Combined vaccines for prophylaxis of infectious conditions. 61
30829068 2019
323
Coptidis Rhizoma: a comprehensive review of its traditional uses, botany, phytochemistry, pharmacology and toxicology. 61
30963783 2019
324
Safety of Co-Administration Versus Separate Administration of the Same Vaccines in Children: A Systematic Literature Review. 61
31906218 2019
325
Vaccination of healthcare personnel in Europe: Update to current policies. 61
31623916 2019
326
Measles, mumps and rubella vs diphtheria-tetanus-acellular-pertussis-inactivated-polio-Haemophilus influenzae type b as the most recent vaccine and risk of early 'childhood asthma'. 61
31062020 2019
327
Protective effects of catalpol and rhein in murine experimental autoimmune encephalomyelitis via regulation of T helper (Th) 1, Th2, Th17, and regulatory T cell responses. 61
32186151 2019
328
Potential effect of age of BCG vaccination on global paediatric tuberculosis mortality: a modelling study. 61
31708146 2019
329
Enhancement of immune response against Bordetella spp. by disrupting immunomodulation. 61
31889098 2019
330
The impact of vaccines on heterologous adaptive immunity. 61
30797062 2019
331
Evaluation of the Seegene Allplex™ Respiratory Panel for diagnosis of acute respiratory tract infections. 61
30307378 2019
332
Developing the concept of beneficial non-specific effect of live vaccines with epidemiological studies. 61
31449870 2019
333
High Prevalence of Macrolide-Resistant Bordetella pertussis and ptxP1 Genotype, Mainland China, 2014-2016. 61
31742507 2019
334
[Impact of whooping cough vaccine during pregnancy on the resurgence of the disease and its form of presentation in paediatric emergency departments]. 61
31889662 2019
335
Differential diagnosis by RT-PCR of Bordetella bronchiseptica in a child without previous pathologic antecedents suffering whooping cough. 61
30392705 2019
336
Early Protection against Pertussis Induced by Live Attenuated Bordetella pertussis BPZE1 Depends on TLR4. 61
31732529 2019
337
Bordetella pertussis antigens encapsulated into N-trimethyl chitosan nanoparticulate systems as a novel intranasal pertussis vaccine. 61
31240957 2019
338
Safety of Maternal Immunization Against Pertussis: A Systematic Review. 61
31531826 2019
339
Incidence of pertussis in the province of Pesaro-Urbino (Italy). 61
31846988 2019
340
Re: Letter to the Editor of Public Health in response to 'Vaccination against pertussis and influenza in pregnancy: a qualitative study of barriers and facilitators.' 61
31204073 2019
341
Influenza and pertussis vaccination of women during pregnancy in Victoria, 2015-2017. 61
31680252 2019
342
Influenza and pertussis vaccination of women during pregnancy in Victoria, 2015-2017. 61
31680257 2019
343
Five-Year Follow-up of a Severe Case of Pertussis in Oregon, 2012. 61
31568732 2019
344
The health and economic burden of pertussis in Canada: A microsimulation study. 61
31585727 2019
345
The prevalence and clinical characteristics of pertussis-associated pneumonia among infants in Botswana. 61
31733643 2019
346
Trends in Hospital Admissions for Pertussis Infection: A Nationwide Retrospective Observational Study in Italy, 2002-2016. 61
31731820 2019
347
Association of sociodemographic factors and internet query data with pertussis infections in Shandong, China. 61
31727192 2019
348
A LONELY GUY protein of Bordetella pertussis with unique features is related to oxidative stress. 61
31745120 2019
349
[Alterations in responses to vaccines in older people]. 61
31522947 2019
350
The evolving nature of Bordetella pertussis in Ontario, Canada, 2009-2017: strains with shifting genotypes and pertactin deficiency. 61
31295416 2019
351
Acceptance of pregnant women's vaccination against pertussis among French women and health professionals: PREVACOQ-1 and -2 studies. 61
31570170 2019
352
Vaccination against Paediatric Respiratory Pathogens. 61
31683882 2019
353
Diphtheria or Streptococcal Pharyngitis: A Case Report Highlighting the Diagnostic Dilemma in the Post-vaccination Era. 61
31890394 2019
354
Human bocavirus in children hospitalized for acute respiratory tract infection in Rome. 61
31776891 2019
355
Mortality reduction benefits and intussusception risks of rotavirus vaccination in 135 low-income and middle-income countries: a modelling analysis of current and alternative schedules. 61
31607466 2019
356
Importance of reasons for stocking adult vaccines. 61
31747238 2019
357
DTaP5-HBV-IPV-Hib pediatric hexavalent combination vaccine for use in children from 6 weeks through to 4 years of age. 61
31697185 2019
358
Childhood pneumonia in low-and-middle-income countries: An update. 61
31422032 2019
359
Alternative splicing event modifying ADGRL1/latrophilin-1 cytoplasmic tail promotes both opposing and dual cAMP signaling pathways. 61
31339586 2019
360
Pathophysiology, causes and genetics of paediatric and adult bronchiectasis. 61
30801930 2019
361
Hexavalent vaccines in preterm infants: an update by Italian Society of Pediatric Allergy and Immunology jointly with the Italian Society of Neonatology. 61
31744514 2019
362
Breastfeeding Prevalence at Time of Vaccination: Results of a Pilot Study in 6 Italian Regions. 61
30657734 2019
363
Developing product label information to support evidence-informed use of vaccines in pregnancy. 61
31594709 2019
364
Differential regulation of Cav2.2 channel exon 37 variants by alternatively spliced μ-opioid receptors. 61
31775826 2019
365
Molecular epidemiology and antimicrobial susceptibility of outbreak-associated Corynebacterium diphtheriae in Thailand, 2012. 61
31472364 2019
366
Measurement of coverage, compliance and determinants of uptake in a publicly funded rotavirus vaccination programme: a retrospective cohort study. 61
31678951 2019
367
Vaccination Status and Resource Use During Hospital Visits for Respiratory Illnesses. 61
31624218 2019
368
Sonic hedgehog enhances calcium oscillations in hippocampal astrocytes. 61
31506300 2019
369
A novel multilocus variable-number tandem repeat analysis for Bordetella parapertussis. 61
31613204 2019
370
T3S injectisome needle complex structures in four distinct states reveal the basis of membrane coupling and assembly. 61
31427728 2019
371
50 Years Ago in TheJournal ofPediatrics: Antimicrobial Treatment of Pertussis. 61
31655695 2019
372
Rare Detection of Bordetella pertussis Pertactin-Deficient Strains in Argentina. 61
31625838 2019
373
Association of Exposure to Civil Conflict With Maternal Resilience and Maternal and Child Health and Health System Performance in Afghanistan. 61
31702799 2019
374
Hexavalent Vaccines in India: Current Status. 61
31729324 2019
375
Respiratory Conditions: Lower Respiratory Tract Infections. 61
31710454 2019
376
Seroprotection at Different Levels of the Healthcare System After Routine Vaccination With Diphtheria-Tetanus-Pertussis whole cell-Hepatitis B-Haemophilus influenzae Type B in Lao People's Democratic Republic. 61
30778522 2019
377
Collaborative study for the calibration of the replacement International Standard for pertussis toxin for use in histamine sensitisation and CHO cell clustering assays. 61
31526657 2019
378
A nested case-control study measuring pertussis vaccine effectiveness and duration of protection in Manitoba, Canada, 1992-2015: A Canadian Immunization Research Network Study. 61
31564453 2019
379
Conserved Patterns of Symmetric Inversion in the Genome Evolution of Bordetella Respiratory Pathogens. 61
31744907 2019
380
Orexin-A protects against oxygen-glucose deprivation/reoxygenation-induced cell damage by inhibiting endoplasmic reticulum stress-mediated apoptosis via the Gi and PI3K signaling pathways. 61
31233841 2019
381
ADVANCE system testing: Benefit-risk analysis of a marketed vaccine using multi-criteria decision analysis and individual-level state transition modelling. 61
31677947 2019
382
Pertussis diagnostic practices of general practitioners in the Netherlands: A survey study. 61
31407603 2019
383
Multiplex Polymerase Chain Reaction Panel for Suspected Pertussis: What About a Positive Mycoplasma pneumoniae Result? 61
31568140 2019
384
Pertussis hospitalizations among term and preterm infants: clinical course and vaccine effectiveness. 61
31664950 2019
385
Pertussis in the Association of Southeast Asian Nations: epidemiology and challenges. 61
31369823 2019
386
Maternal tetanus, diphtheria, and acellular pertussis (Tdap) and influenza immunization: an overview. 61
31645152 2019
387
Seroprevalence of an antibody against diphtheria, tetanus, and pertussis among the elderly in Khon Kaen, Thailand. 61
31627764 2019
388
Vital Signs: Burden and Prevention of Influenza and Pertussis Among Pregnant Women and Infants - United States. 61
31600186 2019
389
Quantifying outcome misclassification in multi-database studies: The case study of pertussis in the ADVANCE project. 61
31677950 2019
390
Pertussis over two decades: seroepidemiological study in a large population of the Siena Province, Tuscany Region, Central Italy. 61
31666278 2019
391
Successful vaccination with tetanus and diphtheria and acelluar pertussis vaccine after adverse reaction to diphtheria and tetanus toxoids and acellular pertussis vaccine or diphtheria and tetanus vaccine in pediatric patients. 61
31228630 2019
392
ADVANCE system testing: Can safety studies be conducted using electronic healthcare data? An example using pertussis vaccination. 61
31677946 2019
393
Advance system testing: Vaccine benefit studies using multi-country electronic health data - The example of pertussis vaccination. 61
31677949 2019
394
ADVANCE system testing: Can coverage of pertussis vaccination be estimated in European countries using electronic healthcare databases: An example. 61
31677953 2019
395
[Febrile seizures, epilepsy, migraine, diabetes, and heart disease as well as measles, chicken pox, and whooping cough in children and adolescents in Germany : Results from KiGGS Wave 2]. 61
31529181 2019
396
Identification of Gain and Loss of Function Missense Variants in MRGPRX2's Transmembrane and Intracellular Domains for Mast Cell Activation by Substance P. 61
31652731 2019
397
Global Epidemiology of Diphtheria, 2000-20171. 61
31538559 2019
398
Pregnant women's knowledge and attitude to maternal vaccination including group B streptococcus and respiratory syncytial virus vaccines. 61
31540809 2019
399
Endocytosis of CF in marginal cells of stria vascularis regulated by ROCK and MLCK signaling cascade, but not G-proteins. 61
30739815 2019
400
Streptococcus pneumoniae and Haemophilus influenzae nasopharyngeal molecular detection in children with acute respiratory tract infection in SANADOR Hospital, Romania. 61
31389781 2019
401
A pre and post intervention study measuring the effect of interactive education on adolescent perceptions of vaccines, vaccine safety and disease risk. 61
31608381 2019
402
[Distrust of vaccination: Why?] 61
31522951 2019
403
Vaccination Coverage with Selected Vaccines and Exemption Rates Among Children in Kindergarten - United States, 2018-19 School Year. 61
31622283 2019
404
Channel Formation by LktA of Mannheimia (Pasteurella) haemolytica in Lipid Bilayer Membranes and Comparison of Channel Properties with Other RTX-Cytolysins. 61
31627319 2019
405
Healthcare workers' knowledge, beliefs, and coverage regarding vaccinations in critical care units in Italy. 61
31564452 2019
406
Role of mPRα (PAQR7) in progesterone-induced Ca2+ decrease in human vascular smooth muscle cells. 61
31416049 2019
407
Efficacy of a Web-Based Intervention to Increase Uptake of Maternal Vaccines: An RCT. 61
31471001 2019
408
Determinants of nurses' willingness to receive vaccines: Application of the health belief model. 61
31162752 2019
409
Mirtazapine increases glial cell line-derived neurotrophic factor production through lysophosphatidic acid 1 receptor-mediated extracellular signal-regulated kinase signaling in astrocytes. 61
31306636 2019
410
Suppression of the Peripheral Immune System Limits the Central Immune Response Following Cuprizone-Feeding: Relevance to Modelling Multiple Sclerosis. 61
31653054 2019
411
A spatial regression model for the disaggregation of areal unit based data to high-resolution grids with application to vaccination coverage mapping. 61
30229698 2019
412
A binding motif for Hsp90 in the A chains of ADP-ribosylating toxins that move from the endoplasmic reticulum to the cytosol. 61
31231933 2019
413
Exploring parents' reasons for incomplete childhood immunisation in Indonesia. 61
31522808 2019
414
Decomposing socioeconomic inequality in child vaccination in the Gambia, the Kyrgyz Republic and Namibia. 61
31558326 2019
415
Home-based records and vaccination appointment stickers as parental reminders to reduce vaccination dropout in Indonesia: A cluster-randomized controlled trial. 61
31564451 2019
416
Global Routine Vaccination Coverage, 2018. 61
31647786 2019
417
Impact of Training of Primary Health Care Centers' Vaccinators on Immunization Session Practices in Wasit Governorate, Iraq: Interventional Study. 61
31593540 2019
418
Infant, maternal and demographic predictors of delayed vaccination: A population-based cohort study. 61
31628032 2019
419
ADVANCE: Towards near real-time monitoring of vaccination coverage, benefits and risks using European electronic health record databases. 61
31677951 2019
420
[Vaccine hesitancy: How to lift the brake?] 61
31522949 2019
421
Pertussis: 100-day Disease Over 50 Years! 61
31724542 2019
422
Commensal Microbes Affect Host Humoral Immunity to Bordetella pertussis Infection. 61
31308086 2019
423
Promiscuous G-Protein-Coupled Receptor Inhibition of Transient Receptor Potential Melastatin 3 Ion Channels by Gβγ Subunits. 61
31451581 2019
424
Paediatric hospitalizations due to whooping cough in Spain (1997-2017). 61
31526619 2019
425
DTaP-IPV-HepB-Hib Vaccine (Hexyon®): An Updated Review of its Use in Primary and Booster Vaccination. 61
31444785 2019
426
Determinants of influenza and pertussis vaccine uptake in pregnant women in Ireland: A cross-sectional survey in 2017/18 influenza season. 61
31515147 2019
427
Single doses of diphtheria-tetanus-pertussis and poliomyelitis vaccines are sufficient to generate a booster-type response to tetanus in most migrant children. 61
31522805 2019
428
Flow cytometry analysis of CD64, CD18, CD11a and CD11b in four children with Bordetella pertussis infection and admitted to critical care: New biomarkers? 61
29287931 2019
429
Activation of HIF-1α by δ-Opioid Receptors Induces COX-2 Expression in Breast Cancer Cells and Leads to Paracrine Activation of Vascular Endothelial Cells. 61
31300611 2019
430
Ellipsometric-based novel DNA biosensor for label-free, real-time detection of Bordetella parapertussis. 61
31375953 2019
431
Insights and expectations for Tdap vaccination of pregnant women in Italy. 61
31456459 2019
432
Experimental autoimmune encephalomyelitis accelerates remyelination after lysophosphatidylcholine-induced demyelination in the corpus callosum. 61
31228686 2019
433
The Association Between Third-Trimester Tdap Immunization and Neonatal Pertussis Antibody Concentration 61
31647210 2019
434
Influenza and pertussis vaccination during pregnancy - attitudes, practices and barriers in gynaecological practices in Germany. 61
31477095 2019
435
Identification of etiologic agents and clinical characteristics for patients suspected of having pertussis in a large Children's Hospital in China. 61
31700879 2019
436
In vitro activity and clinical efficacy of macrolides, cefoperazone-sulbactam and piperacillin/piperacillin-tazobactam against Bordetella pertussis and the clinical manifestations in pertussis patients due to these isolates: A single-centre study in Zhejiang Province, China. 61
30710647 2019
437
Predictors of tetanus, diphtheria, acellular pertussis and influenza vaccination during pregnancy among full-term deliveries in a medically underserved population. 61
31471152 2019
438
The Impact of Early Postpartum Maternal Pertussis Vaccination on the Protection of Infants: A Randomized Clinical Trial. 61
31552831 2019
439
The BvgS PAS Domain, an Independent Sensory Perception Module in the Bordetella bronchiseptica BvgAS Phosphorelay. 61
31235515 2019
440
Spontaneous pneumothorax in an infant: an unusual complication of pertussis. 61
31570363 2019
441
Recurrent immune thrombocytopenia following different vaccines. 61
31540926 2019
442
Parental knowledge and common practices regarding acute respiratory infections in children admitted in a hospital in rural setting. 61
31681665 2019
443
[The Brandenburg Network Healthy Children: Early Prevention Shows Effectiveness]. 61
31529445 2019
444
The 1925 Diphtheria Antitoxin Run to Nome - Alaska: A Public Health Illustration of Human-Animal Collaboration. 61
28032302 2019
445
T Cell Metabolism Is Dependent on Anatomical Location within the Lung. 61
31519702 2019
446
Vaccination uptake among Australian early childhood education staff: assessing perceptions, behaviours and workplace practices. 61
31521116 2019
447
[Primary Health Care-Sensitive Hospitalizations in children under one year of age, from 2008 to 2014, in the State of São Paulo, Brazil]. 61
31508742 2019
448
Comparative transcriptomics between species attributes reactogenicity pathways induced by the capsular group B meningococcal vaccine, 4CMenB, to the membrane-bound endotoxin of its outer membrane vesicle component. 61
31551511 2019
449
Hechtia glomerata Zucc: Phytochemistry and Activity of Its Extracts and Major Constituents Against Resistant Bacteria. 61
31546651 2019
450
Early childhood vaccination and subsequent mortality or morbidity: are observational studies hampered by residual confounding? A Danish register-based cohort study. 61
31537568 2019
451
Trends in governmental expenditure on vaccination programmes in the Netherlands, a historical analysis. 61
31420172 2019
452
Impact assessment of an educational course on vaccinations in a population of medical students. 61
31650050 2019
453
Timeliness and factors associated with rotavirus vaccine uptake among Australian Aboriginal and non-Aboriginal children: A record linkage cohort study. 61
31443995 2019
454
PARPs and PAR as novel pharmacological targets for the treatment of stress granule-associated disorders. 61
31102582 2019
455
Phase 1 trial of a 20-valent pneumococcal conjugate vaccine in healthy adults. 61
31495592 2019
456
Post-translational acylation controls the folding and functions of the CyaA RTX toxin. 61
31226003 2019
457
Out-of-sequence DTP and measles vaccinations and child mortality in Guinea-Bissau: a reanalysis. 61
31492774 2019
458
Seroprotection rates of vaccine-preventable diseases among newly arrived Eritrean asylum seekers in Switzerland: a cross-sectional study. 61
31094415 2019
459
Comparison of the clinical and laboratory characteristics of pertussis or viral lower respiratory tract infections. 61
32074092 2019
460
Immunizations during pregnancy: How, when and why. 61
31226574 2019
461
The Hajj 2019 Vaccine Requirements and Possible New Challenges. 61
31529930 2019
462
Pertussis Toxin: A Key Component in Pertussis Vaccines? 61
31546599 2019
463
The 112-Year Odyssey of Pertussis and Pertussis Vaccines-Mistakes Made and Implications for the Future. 61
30793754 2019
464
Epidemiology of pertussis in Marrakech and contribution of molecular diagnosis. 61
31274041 2019
465
Controlled human infection with Bordetella pertussis induces asymptomatic, immunising colonisation. 61
31562530 2019
466
Toward a Controlled Human Infection Model of Pertussis. 61
31552410 2019
467
Genome characteristics of Bordetella pertussis isolates from Tunisia. 61
31329091 2019
468
Maternal Immunization in the U.S.: A Nationwide Retrospective Cohort Study. 61
31427034 2019
469
A single immunogenicity assay for testing potency of combination DTaP vaccines: Simultaneous quantitation of anti-DT, anti-TT, anti-PTxd and anti-FHA antibodies in Guinea-pig serum with a Luminex®-xMAP® bead-based serological assay. 61
31451353 2019
470
The adjuvanted recombinant zoster vaccine co-administered with a tetanus, diphtheria and pertussis vaccine in adults aged ≥50 years: A randomized trial. 61
31443993 2019
471
A rapid and sensitive recombinase aided amplification assay incorporating competitive internal control to detect Bordetella pertussis using the DNA obtained by boiling. 61
31288091 2019
472
Genetic Variation in the Magnitude and Longevity of the IgG Subclass Response to a Diphtheria-Tetanus-Acellular Pertussis (DTaP) Vaccine in Mice. 61
31547158 2019
473
Immunogenicity of a Quadrivalent Human Papillomavirus Vaccine When Co-Administered with Tetanus-Reduced Diphtheria-Acellular Pertussis and Quadrivalent Meningococcal Conjugate Vaccines in Healthy Adolescents: Results from a Randomized, Observer-Blind, Controlled Trial. 61
31377946 2019
474
[Vaccination During Pregnancy]. 61
31571544 2019
475
Disease outbreaks, healthcare utilization, and on-time immunization in the first year of life. 61
31323339 2019
476
Integration of hexavalent diphtheria, tetanus, acellular pertussis, hepatitis B virus, inactivated poliomyelitis and Haemophilus influenzae type b conjugate vaccine within existing national recommendations following a birth dose of monovalent hepatitis B virus vaccine: results of a systematic review in the Asia Pacific region. 61
31328999 2019
477
Bordetella Adenylate Cyclase Toxin Inhibits Monocyte-to-Macrophage Transition and Dedifferentiates Human Alveolar Macrophages into Monocyte-like Cells. 61
31551332 2019
478
Murine Cytomegalovirus Spread Depends on the Infected Myeloid Cell Type. 61
31092580 2019
479
Adolescent vaccinations: updates for the general practitioner. 61
30939514 2019
480
Randomized study of immune responses to two Tdap vaccines among adolescents primed with DTaP and comparison with results among adolescents primed with DTwP. 61
31301919 2019
481
Pertussis in Latin America and the Hispanic Caribbean: a systematic review. 61
31317794 2019
482
Serosurveillance for vaccine-preventable diseases: A look inside the pertussis experience 61
31529840 2019
483
Proper pertussis vaccination will probably not increase vaccination coverage: a case-control study. 61
31426872 2019
484
Association between the timing of maternal vaccination and newborns' anti-pertussis toxin antibody levels. 61
31153689 2019
485
The effectiveness of maternal pertussis vaccination in protecting newborn infants in Brazil: A case-control study. 61
30948222 2019
486
Resurgence of pertussis in Taiwan during 2009-2015 and its impact on infants. 61
31285158 2019
487
Effectiveness of acellular pertussis vaccine in older adults: nested matched case-control study. 61
31504309 2019
488
National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13-17 Years - United States, 2018. 61
31437143 2019
489
Bordetella pertussis in a four-time kidney transplant recipient: A call for immunization programs at transplant centers. 61
31124247 2019
490
Evaluation of Educational Interventions to Enhance Adolescent Specific Vaccination Coverage. 61
31161606 2019
491
Insurance Reimbursements for Routinely Recommended Adult Vaccines in the Private Sector. 61
31248743 2019
492
Activation of somatostatin receptor 5 suppresses T-type Ca2+ channels through NO/cGMP/PKG signaling pathway in rat retinal ganglion cells. 61
31220522 2019
493
Patch testing children with aluminium chloride hexahydrate in petrolatum: A review and a recommendation. 61
31066081 2019
494
Kainate Receptor-Mediated Depression of Glutamate Release Involves Protein Kinase A in the Cerebellum. 61
31450867 2019
495
Isolation and structural determination of flavan-3-ol derivatives from the Polypodium vulgare L. rhizomes water extract. 61
31538499 2019
496
Vaccine acquired pertussis immunity was weakened at 4 years of age and asymptomatic pertussis infection was suspected based on serological surveillance. 61
31053536 2019
497
Characterization of Vaccination Policies for Attendance and Employment at Day/Summer Camps in New York State. 61
29325483 2019
498
Vaccination Status in Pediatric Solid-Organ Transplant Recipients and Their Household Members. 61
31050613 2019
499
The Effect of Maternal Immunisation During Pregnancy on Infant Vaccine Responses. 61
31517260 2019
500
WNT-3A-induced β-catenin signaling does not require signaling through heterotrimeric G proteins. 61
31235524 2019
501
A systematic assessment of current genome-scale metabolic reconstruction tools. 61
31391098 2019
502
Pre-vaccination screening strategies for the use of the CYD-TDV dengue vaccine: A meeting report. 61
31377079 2019
503
Shaping markets to benefit global health - A 15-year history and lessons learned from the pentavalent vaccine market. 61
31384748 2019
504
Pertussis vaccine is only modestly effective in adults: Another piece in the pertussis puzzle. 61
31504298 2019
505
Pertussis in Latin America: Recent epidemiological data presented at the 2017 Global Pertussis Initiative meeting. 61
31331774 2019
506
Pertussis vaccines and protective immunity. 61
31078081 2019
507
Causes of severe pneumonia requiring hospital admission in children without HIV infection from Africa and Asia: the PERCH multi-country case-control study. 61
31257127 2019
508
Knowledge, attitudes, beliefs and practices of obstetrics-gynecologists on seasonal influenza and pertussis immunizations in pregnant women: preliminary results from North-Western Italy. 61
30938116 2019
509
Impact of nutritional supplementation during pregnancy on antibody responses to diphtheria-tetanus-pertussis vaccination in infants: A randomised trial in The Gambia. 61
31386660 2019
510
Shotgun proteomic analysis of Bordetella parapertussis provides insights into the physiological response to iron starvation and potential new virulence determinants absent in Bordetella pertussis. 61
31325608 2019
511
A low-cost microfluidic platform for rapid and instrument-free detection of whooping cough. 61
31005153 2019
512
Factors associated with missed and delayed DTP3 vaccination in children aged 12 - 59 months in two communities in South Africa, 2012 - 2013. 61
31456549 2019
513
The role of respiratory virus infection in suspected pertussis: A prospective study. 61
31405786 2019
514
Therapeutic effect of vitamin K1 combined with meropenem on the treatment of pertussis syndrome. 61
31258701 2019
515
Severe Bordetella pertussis infection and vaccine issue in Chongqing, from 2012 to 2018. 61
31100420 2019
516
Low prevalence of antibodies against pertussis in pregnant women in Italy. 61
31250813 2019
517
Pertussis Vaccination Failure in the New Zealand Pediatric Population: Study Protocol. 61
31315274 2019
518
Use of Electronic Health Records to Improve Maternal Vaccination. 61
31186144 2019
519
Increased susceptibility to pertussis in adults at childbearing age as determined by comparative seroprevalence study, China 2010-2016. 61
31009653 2019
520
Acellular pertussis vaccine effectiveness and waning immunity in Alberta, Canada: 2010-2015, a Canadian Immunization Research Network (CIRN) study. 61
31164304 2019
521
Antibody responses to Bordetella pertussis and other childhood vaccines in infants born to mothers who received pertussis vaccine in pregnancy - a prospective, observational cohort study from the United Kingdom. 61
30758857 2019
522
Despite high rates of vaccination, pertussis cases are on the rise. Is a new vaccination strategy needed? 61
31289033 2019
523
Vaccinations during pregnancy: a call to sting into action. 61
31373211 2019
524
Immunization Considerations in Pregnancy. 61
31305940 2019
525
[Adverse reactions after repeated doses of anti-tetanus vaccine: scientific evidences]. 61
31887737 2019
526
The use of natural language processing to identify Tdap-related local reactions at five health care systems in the Vaccine Safety Datalink. 61
31128829 2019
527
Agomelatine modulates calcium signaling through protein kinase C and phospholipase C-mediated mechanisms in rat sensory neurons. 61
30443943 2019
528
Recommended immunization schedule for children and adolescents: Committee on Infectious Diseases of the Korean Pediatric Society, 2018. 61
31163961 2019
529
Challenges to Pertussis Control. 61
31182551 2019
530
The immunomodulatory effects of measles-mumps-rubella vaccination on persistence of heterologous vaccine responses. 61
30791143 2019
531
Comparison of antibody response between boys and girls after infant and childhood vaccinations in the Netherlands. 61
31279563 2019
532
National immunization strategies targeting migrants in six European countries. 61
29426661 2019
533
Increasing childhood vaccination coverage of the refugee and migrant population in Greece through the European programme PHILOS, April 2017 to April 2018. 61
31290391 2019
534
Higenamine, a Dual Agonist for β 1- and β 2-Adrenergic Receptors Identified by Screening a Traditional Chinese Medicine Library. 61
31185502 2019
535
Diphtheria Epidemiology in Indonesia during 2010-2017. 61
31699943 2019
536
Do mobile phone-based reminders and conditional financial transfers improve the timeliness of childhood vaccinations in Tanzania? Study protocol for a quasi-randomized controlled trial. 61
31272487 2019
537
Nitric oxide modulates μ-opioid receptor function in vitro. 61
30933370 2019
538
Angiogenic and Arthritogenic Properties of the Soluble Form of CD13. 61
31189572 2019
539
5-HT1B Receptor-Mediated Activation of ERK1/2 Requires Both Gαi/o and β-Arrestin Proteins. 61
30946562 2019
540
Clinical and epidemiological aspects of microcephaly in the state of Piauí, northeastern Brazil, 2015-2016. 61
29963988 2019
541
A Systematic Review for Vaccine-Preventable Diseases on Ships: Evidence for Cross-Border Transmission and for Pre-Employment Immunization Need. 61
31366029 2019
542
[Complications of pertussis]. 61
31315774 2019
543
Severe Pertussis Infections in the United States, 2011-2015. 61
30321305 2019
544
Birth dose of pertussis vaccine. 61
31270866 2019
545
Assays for Determining Pertussis Toxin Activity in Acellular Pertussis Vaccines. 61
31319496 2019
546
Acellular Pertussis Vaccine Effectiveness Over Time. 61
31182549 2019
547
Intracellular Trafficking and Translocation of Pertussis Toxin. 61
31349590 2019
548
Early prevention of pertussis is key. 61
31250811 2019
549
Miller Fisher Syndrome Following Tetanus, Diphtheria, and Pertussis (Tdap) Vaccine. 61
31512652 2019
550
Pertussis detection in children with cough of any duration. 61
31299934 2019
551
Early prevention of pertussis is key - Author's reply. 61
31250812 2019
552
Economic and immunisation safety surveillance characteristics of countries implementing no-fault compensation programmes for vaccine injuries. 61
31213377 2019
553
Whooping Cough in a Young Infant. 61
31291519 2019
554
Immunization of preterms with hexavalent combined diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliovirus-Haemophilus influenzae type b conjugate vaccine: The position of the Italian Pediatric Society. 61
29880242 2019
555
Episodic aphthous stomatitis with fever, arthralgias and lymphadenopathy following multiple upper respiratory infections and pertussis in an adult. A reactive mimicker of PFAPA syndrome? 61
31355616 2019
556
Low tetanus-diphtheria-acellular pertussis (Tdap) vaccine coverage among healthcare workers in a quaternary university hospital in São Paulo, Brazil: need for continuous surveillance and implementation of active strategies. 61
31351815 2019
557
Effect on meningococcal serogroup W immunogenicity when Tdap was administered prior, concurrent or subsequent to the quadrivalent (ACWY) meningococcal CRM197-conjugate vaccine in adult Hajj pilgrims: A randomised controlled trial. 61
31128875 2019
558
Knockout of adenylyl cyclase isoform 5 or 6 differentially modifies the β1-adrenoceptor-mediated inotropic response. 61
31009605 2019
559
[Correlation of behavioral performance with expressions of substance P and neurokinin-1 receptor in the L5-S2 spinal cord of chronic prostatitis rats]. 61
32223081 2019
560
Potential use of Western Australia’s mandatory Midwives Notification System for routinely monitoring antenatal vaccine coverage 61
31203587 2019
561
Pertussis vaccination in pregnancy: how many pediatric hospitalizations could be prevented? 61
31089073 2019
562
Pertactin-Negative and Filamentous Hemagglutinin-Negative Bordetella pertussis, Australia, 2013-2017. 61
31107218 2019
563
Assessment of humoral and cell-mediated immune responses to pertussis vaccination: a systematic review protocol. 61
31182449 2019
564
Influenza and pertussis vaccination of women during pregnancy in Victoria, 2015-2017. 61
31006130 2019
565
Pertussis Morbidity in Children 12-59 Months of Age: A NSW Public Health Network Study. 61
30418359 2019
566
Comparative Assessment of the Whole-cell Pertussis Vaccine Potency Using Serological and Intracerebral Mouse Protection Methods. 61
31232559 2019
567
Lymphocyte morphology supports early diagnosis of Bordetella pertussis infection in neonates. 61
30267136 2019
568
Current antenatal pertussis vaccination guidelines miss preterm infants: An epidemiological study from the Northern Territory. 61
30255494 2019
569
Duration of Immunity and Effectiveness of Diphtheria-Tetanus-Acellular Pertussis Vaccines in Children. 61
31009031 2019
570
Comparative Integrated Omics Analysis of the Hfq Regulon in Bordetella pertussis. 61
31238496 2019
571
Resurgence of Pertussis Infections in Shandong, China: Space-Time Cluster and Trend Analysis. 61
30994096 2019
572
Parental Refusal of Standard-of-Care Prophylactic Newborn Practices: In One Center's Experience, Many Refuse One but Few Refuse All. 61
31061136 2019
573
Clinical study of safety and immunogenicity of pentavalent DTP-HB-Hib vaccine administered by disposable-syringe jet injector in India. 61
30899835 2019
574
Evaluation of enhanced follow-up for pertussis in children aged 5–9 years in Sydney Local Health District, NSW 61
31203582 2019
575
Determinants of Influenza and Pertussis Vaccination Uptake in Pregnancy: A Multicenter Questionnaire Study of Pregnant Women and Healthcare Professionals. 61
30418358 2019
576
Why Should We Advocate Maternal Immunization? 61
31205241 2019
577
Partial ligand-receptor engagement yields functional bias at the human complement receptor, C5aR1. 61
31036565 2019
578
Evaluation of IL-17 Serum Level, Brain Inflammation and Demyelination in Experimental Autoimmune Encephalomyelitis C57BL/6 Mice Model with Different Doses of Myelin Oligodendrocyte Glycoprotein. 61
31522437 2019
579
The Rate of CD4 T Cell Entry into the Lungs during Mycobacterium tuberculosis Infection Is Determined by Partial and Opposing Effects of Multiple Chemokine Receptors. 61
30962399 2019
580
Genotypic and phenotypic adaptation of pathogens: lesson from the genus Bordetella. 61
30921085 2019
581
Rapid Purification of Endotoxin-Free RTX Toxins. 61
31212877 2019
582
Membrane Permeabilization by Pore-Forming RTX Toxins: What Kind of Lesions Do These Toxins Form? 61
31216745 2019
583
Distinct Spatiotemporal Distribution of Bacterial Toxin-Produced Cellular cAMP Differentially Inhibits Opsonophagocytic Signaling. 61
31226835 2019
584
Socioeconomic status differences in parental immunization attitudes and child immunization in Canada: Findings from the 2013 Childhood National Immunization Coverage Survey (CNICS). 61
30904601 2019
585
Vaccine-preventable diseases and vaccination among Italian healthcare workers: a review of current literature. 61
31274016 2019
586
The influence of neonatal Bacille Calmette-Guérin (BCG) immunisation on heterologous vaccine responses in infants. 61
31153688 2019
587
Risk of transmission of vaccine-preventable diseases in healthcare settings. 61
31210537 2019
588
Cholecystokinin type B receptor-mediated inhibition of A-type K+ channels enhances sensory neuronal excitability through the phosphatidylinositol 3-kinase and c-Src-dependent JNK pathway. 61
31215470 2019
589
Semiannual Versus Annual Influenza Vaccination in Older Adults in the Tropics: An Observer-blind, Active-comparator-controlled, Randomized Superiority Trial. 61
30277500 2019
590
Cohort profile : Bandim Health Project's (BHP) rural Health and Demographic Surveillance System (HDSS)-a nationally representative HDSS in Guinea-Bissau. 61
31189684 2019
591
Effectiveness of a multimodal intervention to increase vaccination in obstetrics/gynecology settings. 61
31103367 2019
592
Signaling characteristics and functional regulation of delta opioid-kappa opioid receptor (DOP-KOP) heteromers in peripheral sensory neurons. 61
30776373 2019
593
Increasing antepartum Tdap vaccine administration: A quality improvement initiative. 61
31122862 2019
594
A study comparing the practice of Australian maternity care providers in relation to maternal immunisation. 61
30191552 2019
595
Accuracy and quality of immunization data in Iran: findings from data quality self-assessment survey in 2017. 61
31185983 2019
596
Systematic review and meta-analysis of the association between dimensions of inequality and a selection of indicators of Reproductive, Maternal, Newborn and Child Health (RMNCH). 61
31131102 2019
597
Neonatal Pertussis, an Under-Recognized Health Burden and Rationale for Maternal Immunization: A Systematic Review of South and South-East Asian Countries. 61
31054089 2019
598
Deletion of the α subunit of the heterotrimeric Go protein impairs cerebellar cortical development in mice. 61
31221179 2019
599
Serologic Status of Routine Childhood Vaccines, Cytomegalovirus, and Epstein-Barr Virus in Children With Inflammatory Bowel Disease. 61
30551205 2019
600
Quantifying the consequences of measles-induced immune modulation for whooping cough epidemiology. 61
31056052 2019
601
Association of Pertussis Toxin with Severe Pertussis Disease. 61
31252532 2019
602
Pertussis immunisation in newborn babies. 61
31122771 2019
603
Proteomics of Bordetella pertussis whole-cell and acellular vaccines. 61
31182148 2019
604
Blue Nevus Developing at a Combined Tetanus, Diphtheria, and Pertussis (Tdap) Vaccination Site: Case Report and Summary of Vaccine-Associated Cutaneous Lesions. 61
31497428 2019
605
Genetic analysis of clinical and vaccine strains of Bordetella pertussis by Pulsed-Field Gel Electrophoresis (PFGE), Multi Locus Sequence Typing (MLST) and serotyping. 61
31174694 2019
606
'Links2HealthierBubs' cohort study: protocol for a record linkage study on the safety, uptake and effectiveness of influenza and pertussis vaccines among pregnant Australian women. 61
31227542 2019
607
A CARE-compliant article: a case report of idiopathic brachial neuritis treated with ultrasound-guided electroacupuncture. 61
31083162 2019
608
Immunogenicity of pneumococcal conjugate vaccine formulations containing pneumococcal proteins, and immunogenicity and reactogenicity of co-administered routine vaccines - A phase II, randomised, observer-blind study in Gambian infants. 61
30975570 2019
609
Antigen specific vaccine hesitancy in pregnancy. 61
30992221 2019
610
Substrate specificity of the pyrophosphohydrolase LpxH determines the asymmetry of Bordetella pertussis lipid A. 61
30926608 2019
611
When will the coughing stop? Characteristics of children with pertussis (whooping cough) in Armenia (2014-2018). 61
32049667 2019
612
Mapping diphtheria-pertussis-tetanus vaccine coverage in Africa, 2000-2016: a spatial and temporal modelling study. 61
30961907 2019
613
The Epidemiology of Nationally Reported Pertussis in the United States, 2000-2016. 61
30169627 2019
614
Antenatal vaccination to decrease pertussis in infants: safety, effectiveness, timing, and implementation. 61
29199493 2019
615
Spatio-temporal comparison of pertussis outbreaks in Olmsted County, Minnesota, 2004-2005 and 2012: a population-based study. 61
31110089 2019
616
Seroprevalence of antibodies for pertussis and diphtheria among people leaving or entering China: a cross-sectional study. 61
32053508 2019
617
Evaluation of the Aries Bordetella Assay for Detection and Identification of Bordetella pertussis in Nasopharyngeal Swab Specimens. 61
30787143 2019
618
Determinants of satisfaction with information and additional information-seeking behaviour for the pertussis vaccination given during pregnancy. 61
30975566 2019
619
Quantitative determination of bioactive proteins in diphtheria tetanus acellular pertussis (DTaP) vaccine by liquid chromatography tandem mass spectrometry. 61
30831450 2019
620
Metabolites of lactic acid bacteria present in fermented foods are highly potent agonists of human hydroxycarboxylic acid receptor 3. 61
31120900 2019
621
Chaperone-assisted expression and purification of putrescine monooxygenase from Shewanella putrefaciens-95. 61
30654014 2019
622
Membrane Permeabilization by Bordetella Adenylate Cyclase Toxin Involves Pores of Tunable Size. 61
31083482 2019
623
Vaccine safety in HIV-infected adults within the Vaccine Safety Datalink Project. 61
31064675 2019
624
Adverse events following immunisation with four-component meningococcal serogroup B vaccine (4CMenB): interaction with co-administration of routine infant vaccines and risk of recurrence in European randomised controlled trials. 61
31110098 2019
625
Vaccination status of resident pediatricians and the potential risk for their patients - a cross-sectional questionnaire study in pediatric practices in Vienna. 61
31096960 2019
626
Missed Opportunities for Rotavirus Vaccination. 61
31023829 2019
627
Dispensable role of chemokine receptors in migration of mycobacterial antigen-specific CD4+ T cells into Mycobacterium-infected lung. 61
30795859 2019
628
The utility of peripheral blood leucocyte ratios as biomarkers in infectious diseases: A systematic review and meta-analysis. 61
30802469 2019
629
Opioid-Mediated Modulation of Acid-Sensing Ion Channel Currents in Adult Rat Sensory Neurons. 61
30808671 2019
630
Improving immunization strategies in patients with inflammatory bowel disease. 61
31040621 2019
631
Clinical and epidemiological characteristics of whooping cough in hospitalized patients of a tertiary care hospital in Peru. 61
31141085 2019
632
The burden of pertussis in older adults: what is the role of vaccination? A systematic literature review. 61
30887849 2019
633
PERISCOPE: road towards effective control of pertussis. 61
30503084 2019
634
Improvement in serological diagnosis of pertussis by external quality assessment. 61
30990403 2019
635
SEVERE PERTUSSIS IN CHILDHOOD: UPDATE AND CONTROVERSY - SYSTEMATIC REVIEW. 61
31116241 2019
636
In Vivo Gene Essentiality and Metabolism in Bordetella pertussis. 61
31118307 2019
637
Bordetella pertussis Can Be Motile and Express Flagellum-Like Structures. 61
31088927 2019
638
Respiratory Viruses Frequently Mimic Pertussis in Young Infants. 61
30986792 2019
639
Maternal immunization: A call to accelerate progress. 61
31014962 2019
640
Acquisition of specific antibodies and their influence on cell-mediated immune response in neonatal cord blood after maternal pertussis vaccination during pregnancy. 61
30955978 2019
641
Pertussis vaccine effectiveness in a frequency matched population-based case-control Canadian Immunization Research Network study in Ontario, Canada 2009-2015. 61
30967309 2019
642
Randomized Controlled Trial of the Safety and Immunogenicity of Revaccination With Tetanus-Diphtheria-Acellular Pertussis Vaccine (Tdap) in Adults 10 Years After a Previous Dose. 61
29438562 2019
643
Erratum: Who gives pertussis to infants? Source of infection for laboratory confirmed cases less than 12 months of age during an epidemic, Sydney, 2009. (Article originally published in Commun Dis Intell Q Rep 2010;34(2):116-21). 61
31117930 2019
644
The Impact of Conflict on Immunisation Coverage in 16 Countries. 61
31050966 2019
645
A Comparison of the Ability of Leu8- and Pro8-Oxytocin to Regulate Intracellular Ca2+ and Ca2+-Activated K+ Channels at Human and Marmoset Oxytocin Receptors. 61
30739093 2019
646
Integrated Safety Profile of a New Approved, Fully Liquid DTaP5-HB-IPV-Hib Vaccine. 61
30882742 2019
647
Maternal Immunization. 61
30913173 2019
648
Role of Evolutionary Selection Acting on Vaccine Antigens in the Re-Emergence of Bordetella Pertussis. 61
30995764 2019
649
Analysis of the In Vivo Transcriptome of Bordetella pertussis during Infection of Mice. 61
30996109 2019
650
Awareness, Knowledge, and Coverage of Vaccination Against Tetanus, Diphtheria, and Pertussis Among Medical Students of Karachi: A Cross-sectional Analysis. 61
31249750 2019
651
The effectiveness and safety of pertussis booster vaccination for adolescents and adults: A systematic review and meta-analysis. 61
31008974 2019
652
[Compliance with adult measles and pertussis vaccination recommendations : Analysis of data from the national monitoring system KV-Impfsurveillance]. 61
30805673 2019
653
Age-related differences in antibody avidities to pertussis toxin and filamentous hemagglutinin in a healthy Japanese population. 61
30930008 2019
654
Mapping vaccination coverage to explore the effects of delivery mechanisms and inform vaccination strategies. 61
30967543 2019
655
[Update on vaccines: 2018 recommendations]. 61
31833342 2019
656
BspR/BtrA, an Anti-σ Factor, Regulates the Ability of Bordetella bronchiseptica To Cause Cough in Rats. 61
31019000 2019
657
Diphtheria: The Patch Still Remains-A Case Report From the State of Uttarakhand. 61
31148898 2019
658
Child and adolescent health in northwestern Syria: findings from Healthy-Syria 2017 study. 61
31143699 2019
659
Proinsulin C-Peptide Enhances Cell Survival and Protects against Simvastatin-Induced Myotoxicity in L6 Rat Myoblasts. 61
30987105 2019
660
A comparative study of the complete lipopolysaccharide structures and biosynthesis loci of Bordetella avium, B. hinzii, and B. trematum. 61
30578925 2019
661
Parents' Experiences and Nurses' Perceptions of Decision-Making About Childhood Immunization. 61
31039630 2019
662
[Methodology of the 2nd seroprevalence study in Spain]. 61
31006772 2019
663
A 6-year Prospective, Observational, Multi-Center Post-Marketing Surveillance of the Safety of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis (Tdap) Vaccine in Korea. 61
30940999 2019
664
Postvaccination Fever Response Rates in Children Derived Using the Fever Coach Mobile App: A Retrospective Observational Study. 61
31008712 2019
665
Rapid and reasonable molecular identification of bacteria and fungi in microbiological diagnostics using rapid real-time PCR and Sanger sequencing. 61
30858006 2019
666
Melanocortin type 4 receptor-mediated inhibition of A-type K+ current enhances sensory neuronal excitability and mechanical pain sensitivity in rats. 61
30745360 2019
667
Intrinsic planar polarity mechanisms influence the position-dependent regulation of synapse properties in inner hair cells. 61
30975754 2019
668
Regulator of G Protein Signaling Protein 12 (Rgs12) Controls Mouse Osteoblast Differentiation via Calcium Channel/Oscillation and Gαi-ERK Signaling. 61
30489658 2019
669
[Vaccination coverage of children and adolescents in Germany: New data from KiGGS Wave 2 and trends from the KiGGS study]. 61
30788538 2019
670
A step beyond the hygiene hypothesis-immune-mediated classes determined in a population-based study. 61
30961604 2019
671
Bordetella pertussis Infection in Infants and Young Children in Shanghai, China, 2016-2017: Clinical Features, Genotype Variations of Antigenic Genes and Macrolides Resistance. 61
30882726 2019
672
Maternal Pertussis Vaccination During Pregnancy. 61
30932462 2019
673
Pertactin-deficient Bordetella pertussis isolates in Poland-a country with whole-cell pertussis primary vaccination. 61
30580013 2019
674
Genomic Survey of Bordetella pertussis Diversity, United States, 2000-2013. 61
30882317 2019
675
Maternal pertussis immunisation as the first infant dose. 61
30938291 2019
676
Genome Sequence of Bordetella pertussis Vaccine Strain BP 165. 61
31000545 2019
677
Pertussis (whooping cough) is common in teens and adults. 61
30967372 2019
678
Utility of peripheral blood smear in rapid diagnosis of Pertussis. 61
30480363 2019
679
Pertussis surveillance in a children hospital in Bangkok, Thailand. 61
30684746 2019
680
Prenatal vaccination of mothers and hepatitis B vaccination of their infants. 61
30763628 2019
681
Policy support for expanding the adolescent vaccine school mandate in Pennsylvania to include the human papillomavirus (HPV) vaccine. 61
30681651 2019
682
Small interface changes have dramatic impacts: how mandatory fields in electronic medical records increased pertussis vaccination rates in Australian obstetric patients. 61
31039118 2019
683
Maternal pertussis vaccination and its effects on the immune response of infants aged up to 12 months in the Netherlands: an open-label, parallel, randomised controlled trial. 61
30938299 2019
684
Development and validation of magnetic bead pentaplex immunoassay for simultaneous quantification of murine serum IgG antibodies to acellular pertussis, diphtheria and tetanus antigens used in combination vaccines. 61
30690077 2019
685
Child-parent immunization survey: How well are national immunization recommendations accepted by the target groups? 61
31384735 2019
686
Bordetella parapertussis Bacteremia: Clinical Expression and Bacterial Genomics. 61
30976607 2019
687
Probiotics and the immunological response to infant vaccinations; a double-blind randomized controlled trial. 61
30099133 2019
688
Vaccination Practices Among Obstetrician/Gynecologists for Non-pregnant Patients. 61
30777161 2019
689
[Blood exchange transfusion for treatment of severe pertussis in an infant].